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The extracellular matrix (ECM) is a complex, interactive, and dynamic protein 
mesh which provides support for cells through physical scaffolding and affords essential 
biochemical and mechanical cues about the surrounding environment. This non-cellular 
component of tissues can be maintained via cell regulation and recruitment of activated 
fibroblasts as well as from other contributing factors associated with the ECM. When there 
is dysregulation of the biochemical and mechanical (biophysical) cues the ECM provides 
to cells, fibrosis, a scar-like disease, can occur.  
Idiopathic Pulmonary Fibrosis (IPF) is a disease where scar tissue forms in the 
lungs and the organ thickens and becomes rigid or stiff. In IPF the wound healing process 
is initiated and excessive matrix is assembled into a fibrotic state, excessive fibrous 
connective tissue and the cause for dysregulation of the normal wound healing process is 
unknown. As required cell-derived forces initiate remodeling the dynamics of the ECM 
turnover rate are increase within a fibrotic tissue. Increased stiffness in the direct 
environment could prevent mechanical deformation of protein in the local matrix; however, 
based on unpublished work from Thomas Barker’s lab it is suggested that in the fibroblastic 
foci the tissue is soft and elastic. It is believed that the ECM proteins here may become 
strained and deformed, spatially changing conformation and providing different 
mechanical and biochemical cues to the cells in this environment and constitutive activity 
of the fibroblasts present at the site of injury. The IPF disorder is pervasive, affecting 5 
million people worldwide1. Treatment is limited and life expectancy is short resulting in 
grave impacts on quality of life for patients. Tissue fibrosis is a necessary process important 
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to tissue repair. Fibrotic diseases are characterized by the dysregulation of matrix 
deposition that occurs leading to a disruption to matrix architecture and function which 
further leads to the characteristic excessive scar tissue formation. Fibroblasts become 
activated in the fibrotic environment which causes them to proliferate and secrete excessive 
amounts of ECM proteins, which then causes the environment to stiffen. Once the 
environment is stiff, then the fibroblasts may respond by becoming even further “activated” 
with increased contraction and other myofibroblast phenotype characteristics. 
Myofibroblast differentiation, activated fibroblasts, and cell contraction based cell-derived 
forces lead to physical unfolding and stiffening of the ECM. Within the diseased state a 
feed-forward is established where the wound healing responses and fibrobasts never revert 
from their activated state even after healing has occurred. 
Proteins which comprise the matrix structure can become displaced and undergo 
cell traction force mediated partial unfolding. A stable intermediate is believed to be 
present which provides integrin selectivity for cells. These strained states of Fn will 
influence cell-ECM interactions ultimately leading to effects on cell phenotype. Cell-ECM 
interactions through cell-surface receptors, integrins, are greatly impacted when matrix 
alterations cause integrin preferences to change affecting many downstream signaling 
events which influence cell phenotype. FAK and Src are both integrin associated focal 
adhesion complex proteins that can influence cell migration, mechano-sensing, and 
proliferation. 
One ECM protein that is especially interesting is fibronectin (Fn) because its 
expression and deposition in tissues following injury are distinctly increased. During repair 
there is an excess deposition of fibronectin into the ECM associated with fibrosis. It is 
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believed that polymerized fibronectin may serve as a precursor to collagen deposition. A 
more thorough understanding of the role of Fn’s IBD in regulating cell activities which 
contribute to the development of fibrosis is necessary and explored in this work. 
Elucidating the impacts of Fn’s IBD on fibroblasts is central to being able to mimic naïve 
and fibrotic environments for cell studies and for identifying key targets for therapeutic 
options. As such, the overall aim of this work is to identify cell responses to changes in the 
integrin binding domain of Fn to be able to determine which cell behaviors are resultant 
from the change in biochemical cues.  
Integrin engagement can affect cell behaviors such as adhesion, migration and 
differentiation, as well as direct more coordinated behaviors like wound remodeling. Over 
the past decade, several groups have developed recombinant Fn fragments that engage 
specific integrins leading to distinct cellular responses. The mechanics of the Fn molecule 
are thought to be an important regulator of integrin specificity. Integrin-switch behavior 
has been introduced as a likely hypothesis. This theorizes that integrin engagement can be 
controlled based on the conformation of the integrin binding domain of Fn evidenced in 
the engagement of α5β1 on relaxed Fn fibers and equivalent engagement of αvβ3 on both 
relaxed and strained Fn matrices. The integrin α5β1 appears to be turned “off” when 
presented with “strained” conformations of Fn indicating that it engages with the 
promiscuous RGD integrin binding site as well as the spatially coordinated “synergy” site, 
PHSRN. Moving forward, the field will benefit from experimental evidence of this 
mechano-sensitive integrin switch hypothesis as well as further engineering advances in 
Fn-based tissue engineering strategies2. 
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Biochemically, Fn fragments displaying the synergistic RGD and PHSRN binding 
sites facilitate cell binding through α5β1 integrins. Presentation of these domains in a 
specific conformation can lead to the influence on fibroblast phenotype. Smith et al. 
showed that extended Fn fibers can decrease cell spreading and adhesion3. Cells have the 
ability to bind RGD if they have access to this region contained in FnIII10. Fn fragments 
that display the RGD and PHSRN site with 4 Glycine linker, removing the presence and 
orientation of these synergistic sites and therefore the synergistic effect of the two sites, 
facilitates cell binding primarily through αv integrins. This work indicates that there are 
differential responses in cell behavior based on if cells engage αvβ3 or α5β1 integrins. 
Since these integrins are the two key integrins known to bind to Fn they are of particular 
interest; however, their direct influence on cell behavior within lung fibroblasts has not 
been studied extensively. Steered molecular dynamics simulations have been performed in 
order to predict the structural states of Fn’s integrin binding domain under force which 
indicate that “extended” conformation displaces the RGD and “synergy” sites4. It is 
believed that by mimicking the extended conformation of FnIII9-10 (IBD) with a 
recombinant fragment by spatially separating the sites with a 4 Glycine linker designed to 
engage only αvβ3 integrins. Engagement of this integrin alone is believed to lead to 
enhanced activation of fibroblasts and ultimately a more myo-like fibroblastic profile. It 
has been shown by Liu et al. and others that β1 integrins are implicated in activated 
fibroblasts necessary for tissue repair in vivo5,6. Specifically, enhanced β1 binding is 
associated with increased cell contractility through the rho-ROCK pathway.  These effects 
are not solely on or off but presentation of variations between RGD and PHSRN distance 
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can have influence on integrin engagement. Certain pathways can be activated based on 
integrin engagement.  
An in depth investigation into integrin-switch behavior and the downstream 
phenotypic changes that are affected in fibroblasts is examined. There are biochemical cues 
that we have previously explored with epithelial cells, that can direct cell behavior and I 
want to explore this effect of a normal human lung fibroblast to act more myo-like if 
directed with preferential integrin engagement. Biophysically, mechanical stiffness can 
also be an influencing factor sufficient to cause myofibroblast transition. The results 
explored through analyzing the cellular response to micro-mechanical environment and 
matrix presentation could likely be attributed to phenotypic changes of lung fibroblasts, 
particularly those often associated with fibrotic disease progression. 
It is important to further understand the physiological processes that result in 
normal wound remodeling vs. progressive fibrosis. In this thesis the biochemical and 
biophysical cues that influence cell response to environmental changes will be explored. 
We examine Fn’s IBD as recombinant peptides that mimic the protein in a relaxed or 
strained conformation and find that there is an influence on cell behavior based on 
presentation of RGD and PHSRN. The work in this Thesis provided a clearer 
understanding of how the fate of a fibroblast can be defined and regulated based on 
biochemical changes in cell microenvironment. This work in combination with biophysical 
regulation through substrate stiffness could provide testing environments to determine the 
total effects that the cell microenvironment can have on cell fate. 
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CHAPTER 1. INTRODUCTION 
1.1 Specific Aims 
Fibrosis predominantly occurs in soft tissues through fibroblast proliferation and 
deposition of extracellular matrix (ECM)7,8. Pulmonary fibrosis is a disease involving 
advanced scarring of the lung tissue resulting in the thickening and ultimately stiffening of 
the lung. Chronic fibrotic disorders are plagued by unrelenting fibrotic remodeling which 
disrupts normal microenvironment structure and can ultimately impair organ function. 
Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal fibrotic disorder affecting 
50 of every 100,000 Americans with an average survival rate of 3 years post diagnosis9,10. 
The current understanding of the causes of this condition are not known, and there is no 
present cure or widely accepted treatments9-11. In IPF, recruitment and constitutive activity 
of fibroblasts causes the excessive deposition of ECM proteins resulting in scar formation 
and lung stiffness. Fibrogenesis is thought to be driven by excessive matrix deposition and 
abnormal myofibroblast contractility and results in alterations to the mechanical properties 
of tissues12. Pathologically this is relevant because alterations in extracellular mechanics 
can modify cell behavior such that rigid ECM leads to fibroblast activation towards a state 
of increased matrix synthesis and proliferation13-15. Cells are able to sense and respond to 
the ECM as it is a biochemical and mechanical environment. It is known that specific 
integrin signaling is present within stiff cellular environments16. Integrin-switch behavior 
is a hypothesized mechanism regulated by the spatial relationship of RGD and “synergy” 
site, PHSRN, on the Fn integrin binding domain. It has been implicated that through 
separation of these two integrin binding sites engagement of α5β1 integrin is switched “off” 
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opposed to αvβ3 integrins which engage RGD alone or when the two sites are 
confomationally stable. Specific integrin signaling leads to enhanced fibroblast activation 
(i.e. enhanced proliferation, resistance to apoptosis, migration/invasion, and ECM 
synthesis); however, the details of the effects of differential integrin engagement on 
downstream signaling are still largely unknown. Underlying matrix stiffness also 
influences cell fate because it has been proven that cells will alter their internal stiffness to 
match their surroundings as a response to substrate stiffness which can ultimately lead to 
increased cell contractility and ultimately a more myofibroblastic phenotype17. 
Discovering new therapeutic targets that could inhibit the progressive nature of this disease 
is critical for patient survival and quality of life.  
Myofibroblasts are the primary effector cell in IPF. Fibrosis is evident by increased 
deposition of extracellular matrix proteins and myofibroblast presence. Myofibroblastic 
cells will have a contractile phenotype and are characterized by the appearance of α-smooth 
muscle actin18. Myofibroblasts are likely to be derived by activation/proliferation of local 
lung fibroblasts, though their origins are still debated. Therapeutic treatments of IPF could 
benefit by interfering with the pathways that lead to myofibroblast expansion; however, it 
is important to first understand the differential engagement of the lung fibroblast integrin-
switch and how it leads to potentiation of myofibroblast phenotype differentiation. Since 
fibroblasts are responsible for and sensitive to changes in ECM rigidity, understanding how 
fibroblasts “sense” and “respond” to their environment is of key importance to understand 
the pathology of IPF. Fibroblasts are responsible for Fn IBD conformational changes and 
this work seeks to explore their sensitive to these changes. 
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Fibronectin, an ECM protein that is assembled into fibers serving as a provisional 
matrix is important in would healing. Fibronectin interacts with cells via cell surface 
receptors called integrins. Molecular dynamic simulations have suggested that under 
tensile force there is a conformational change within the integrin binding domain of 
fibronectin that is hypothesized to skew the affinity of specific integrin heterodimers to 
Fn19-23. This partial unfolding of Fn’s type III repeats under tensile force outlines a possible 
mechanism for the mechanical force of the extracellular environment to have influence on 
intracellular signaling. We have developed recombinant fragments of Fn’s integrin binding 
domain that mimic the predicted “relaxed” and “strained” states.   
1.1.1 Hypothesis 
Loss of fibroblast engagement of Fn via the α5β1 integrin drives myofibroblast 
differentiation 
This approach seeks a deeper understanding of the biochemical effects on cell 
behavior which can ultimately lead to IPF. Current treatment options are widely 
unavailable (lung transplant) or only slow disease progression (pirfenidone and 
nintedanib)24-26. Since we know that myofibroblasts are a primary effector in IPF we hope 
to better understand the influence that integrin engagement has on determining 
myofibroblast phenotype in order to explore therapeutic options that could selectively 
inhibit αvβ3 integrin and not α5β1 integrin interaction with fibronectin27. Investigating the 
assembly of stress fibers and focal adhesion structures can provide insight into the 
biochemical signaling, mechano-transduction, as cells transduce rigidity cues28. Further 
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understanding of the cell-matrix interaction will allow us to understand how a potential 
therapeutic could affect cell behaviors. 
In this thesis, my objective was to further understand the cellular responses based 
on differential integrin engagement through exploration of cell signaling events and 
myofibroblast characteristics. This was accomplished using qualitative standard cell 
biological practices and phenotypic characterization methods with these (2) aims: 
1.1.2 Specific Aim 1 
Observe how fibronectin’s integrin binding domain (reflected by recombinant fibronectin 
fragments) triggers differential integrin engagement (integrin-switch) in lung fibroblasts 
and affects focal adhesion associated signaling proteins 
1.1.2.1 Characterize “integrin switch” with α5 and αv integrin immunostaining on 
FnIII9-4G-10 and FnIII9*10 
1.1.2.2 Investigate the quality of focal adhesions on FnIII9-4G-10 and FnIII9*10 over 
time 
1.1.2.3 Determine force-mediated focal adhesion components (FAK and Src) associated 
with FnIII9-4G-10 and FnIII9*10 
1.1.3 Specific Aim 2 
Characterize phenotype due to conformational bias of recombinant fibronectin integrin 
binding domain.  
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1.1.3.1 Evaluate lung fibroblast cell contractility (via size and shape) on FnIII9-4G-10 
and FnIII9*10 
1.1.3.2 Asses cell proliferation and metabolism on FnIII9-4G-10 and FnIII9*10 
1.1.3.3 Calculate MRTF nuclear localization on FnIII9-4G-10 and FnIII9*10  
To evaluate the influence of the integrin binding domain of Fn, recombinant protein 
fragments which were previously designed will be used. Design of an optimized protein 
production system was performed for ease of use for evaluation efforts of human lung 
fibroblasts and their pathway through myofibroblast differentiation.  Spatial decoupling of 
the cell binding motifs (RGD and PHSRN) within the cell binding domain of fibronectin 
are expected to produce phenotypic shifts in lung fibroblasts in important wound healing 
phenotypes.   
Early analysis of integrin binding by SPR and lung fibroblast adhesion on these 
substrates indicated a switch in the integrins engaged for attachment and spreading; 
fibroblasts engage a greater ratio of  α5β1 integrin on FnIII9*10, whereas they display an 
increased shift in ratio towards integrin αvβ3 on FnIII9-4G-1029. Analysis of the influence 
of this differential integrin engagement should be completed through further evaluation of 
focal adhesion markers, resistance to apoptosis and myofibroblast differentiation markers. 
Through our previous work on Fn’s hypothesized integrin switch effects on epithelial-to-
mesenchymal transition we were led to hypothesize that the extended conformation of Fn’s 
integrin binding domain will enhance myo-like differentiation (myofibroblastic) and 
resistance to apoptosis. In the work looking at epithelial cells it was shown that these 
engineered integrin-specific recombinant Fn fragments can be used to guide cell 
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phenotype30. It was hypothesized that a similar approach could be taken to explore if 
fibroblast to myofibroblast transition occurred in normal human lung fibroblasts. 
The innovative nature of this project comes from the exploration of the relationship 
of the integrin- switch behavior with cell fate. Current studies of Fn conformational change 
have been limited to molecular dynamics simulations and AFM studies. These experiments 
have supported theories about Fn conformation change but they have not explored the 
physiological relevance or examination of these changes in native ECM. Exploration of 
these recombinant Fn integrin binding domain proteins on differential integrin engagement 
and impact on lung fibroblast behavior is a novel pursuit. Based on previous work and our 
expertise we expect that when the synergistic effect of RGD and PHSRN is reduced and 
α5β1 is no longer engaged and the primary integrin engaged is αvβ3 there will be a change 
in fibroblast fate leading to differential focal adhesion component association and 
downstream internal cell signals that results in a more myofibroblastic phenotype. This 
work is impactful because it associates specific stimuli (mechanical and biochemical) with 
myofibroblast differentiation and ultimately events that are related to lung fibrosis. 
This project has the potential to advance the field by furthering our understanding 
of the integrin engagement behavior that likely contributes to the recruitment of fibroblasts 
and the phenotypic characteristics of lung fibroblasts associated with Fn presentation, both 
of which could lead to the excessive deposition of extracellular matrix which is ultimately 
the primary contributor to fibrosis and in particular the relevance we see for specific lung 
diseases, such as idiopathic lung fibrosis. Current research focuses on therapeutic targets 
to inhibit further fibrosis. While this is useful information, it is advantageous to also 
understand if the specific integrin engagement can be a potential target for therapeutics and 
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if αvβ3 can be solely responsible for myofibroblast phenotype. Here, we explore these 
recombinant Fn fragments to probe important wound healing phenotypes of fibroblasts, 
such as proliferation, mechano-transduction and myofibroblastic differentiation. The 
potential of a detailed comprehension of fibrotic integrin mechano-switch interactions 
could greatly expand the way that IPF is treated. 
1.1.4 Significance 
The extracellular matrix (ECM) comprises the non-cellular component of tissues, 
including water, proteins, and polysaccharides. Although the basic components remain the 
same, the ECM of each tissue has a unique composition and organization that leads to a 
wide diversity of ECM arrangement and structure in the body. Additionally, the ECM of a 
tissue is highly dynamic, and undergoes remodeling by cells through both enzymatic and 
non-enzymatic processes. Fibrous ECM proteins such as collagen and fibronectin (Fn), 
form complex 3D scaffolds that mechanically support cells and form the basis of tissue 
shape31. This support can exert signaling cues through a process known as mechano-
transduction. For example, varying the rigidity of ECM substrates can influence cell 
behaviors such as adhesion, migration, and differentiation32-34. However, the role of the 
ECM is not limited to mechanical support. ECM components also provide numerous 
biochemical cues to cells through the presentation of specific amino acid binding 
sequences. Cells bind to ECM proteins primarily through ECM receptors called, 
integrins35-37, which then directly initiate signaling responses that can affect cell behavior 
and direct coordinated physiological responses38. 
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Fn is an excellent example of an ECM protein that is intricately involved in cell 
behavior. With binding sites for integrins, other ECM proteins, growth factors, and other 
Fn molecules, Fn is a mediator in many cellular interactions with the ECM39. As a result, 
Fn plays a key role in cell behaviors such as adhesion, migration, and differentiation, as 
well as more coordinated tissue behaviors such as morphogenesis and wound healing. Fn 
is capable of binding a number of different integrins, and growing evidence suggests that 
the selectivity of integrin engagement can drive distinct cell responses. In this thesis, I 
discuss in detail the fundamentals of Fn-integrin interactions, the mechanical properties of 
Fn that may contribute to the specificity of integrin engagement, and the physiological 
consequences of integrin specificity.  
In response to injury the wound healing process is initiated and can for unknown 
reasons enter into overdrive with potential feed-back loops accelerating without restraint 
resulting in fibrosis. Progressive loss of lung elasticity and respiratory capacity can be the 
result of this scar tissue build up. Particularly in idiopathic lung fibrosis, the exact causes 
of fibroblast dysregulated continuous activation are still unclear but there is reason to 
believe that minor injury occurs in the lungs caused by irritants such as smoke inhalation 
or particulate matter present in many smoggy environments in combination with genetic 
pre-disposition to react adversely which trigger resident fibroblasts to synthesize, 
assemble, and remodel their ECM through excessive protein deposition. This diagnosis is 
fatal with a prognosis of approximately 3-5 years. Pulmonary fibrosis is known to be result 
of the cells constitutive activation and excessive matrix deposition. This matrix deposition 
is signaled by specific cell surface receptors. Evidence of active fibrosis is exhibited by 
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increased number of activated fibroblasts, many of which have the phenotypic 
characteristics of myofibroblasts.  
Specifically in IPF, the extracellular matrix (ECM) is constitutively produced 
resulting in scar formation and lung stiffness. It is known that specific integrin signaling is 
present within stiff cellular environments which in turn lead to enhanced fibroblast 
activation (i.e. enhanced proliferation, resistance to apoptosis, migration/invasion, and 
ECM synthesis).  
Further understanding the effects that matrix mechanics and triggered signaling can 
have on cell fate and disease pathophysiology can be used to understand the 
mechanobiology of the lungs and the pathological implications of tissue stiffness and 
strain40-42. Since fibroblasts are the drivers of fibrotic progression understanding how they 
sense and respond to biochemical and mechanical cues is essential to better understand 
lung physiology in vivo. This work is aimed towards discovering novel molecular pathways 
for therapeutic targets in IPF.  
Cells communicate with the ECM protein Fn through integrin receptors on the cell 
surface. Controlling integrin-Fn interactions offers a promising approach to directing cell 
behavior such as adhesion, migration, and differentiation, as well as coordinated tissue 
behaviors such as morphogenesis and wound healing. Several different groups have 
developed recombinant fragments of Fn that can control epithelial to mesenchymal 
transition, sequester growth factors, and promote wound healing43. It is thought that these 
physiological responses are in part due to specific integrin engagement.  
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Furthermore, it has been postulated that the integrin-binding domain of Fn is a 
mechanically sensitive “switch” that drives binding of one integrin heterodimer over 
another. Although computational simulations have predicted the mechano-switch 
hypothesis and recent evidence supports the existence of varying strain states of Fn in vivo, 
experimental evidence of the Fn integrin switch is still lacking but through the publication 
of our work in Cao et al. the evidence is more clear in vitro29. This work indicates that there 
is influence of Fn presentation on initial cell integrin engagement, focal adhesion formation 
and signaling, downstream cell behavior, and eventual influence on cell phenotype. 
Evidence of the integrin mechano-switch will enable the development of new Fn-based 
peptides in tissue engineering and wound healing, as well as deepen our understanding of 
ECM pathologies, such as fibrosis. 
Cell interactions with the extracellular matrix (ECM) can drive not only cell 
behaviors such as adhesion and migration, but also contribute to wound healing. 
Fibronectin (Fn), a cell-adhesive ECM protein, has been studied for several decades, yet 
still offers a rich variety of new information regarding its interaction with cells and other 
components of the extracellular environment. This thesis focuses on Fn-integrin 
interactions, and their subsequent effect on cell and tissue behavior. Recent advances in 
engineering recombinant Fn-based protein fragments are also discussed. 
Engineer fragments are used to mimic work that was initially explore in silico. 
Molecular dynamics simulations have suggested that when applied forces are present Fn’s 
10th III repeat can partially unfold. The intermediate state that is then represented has a 
distance between the 9th and 10th type III repeat leading to downstream effects on cell 
behavior. The indicated spatial separation of the two key binding sites RGD and PHSRN 
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present in FnIII9-10 can implicate mechano-transduction effects. Engineered recombinant 
Fn fragments are attractive as a guide for cell phenotype because they could help interpret 
effects sensitive to force mediated translocation. 
To interpret effects of ECM proteins effects on cell behavior recombinant peptides 
are utilized to track the downstream effects based on differential integrin engagement. Fn 
is known to be present in the ECM of injured tissues undergoing regeneration. Latent 
wound healing can be promoted by controlling Fn’s integrin binding domain.  Fn’s 
integrin-binding domain has been studied and recombinant Fn fragments that contain this 
region are of particular interest due to the relevance to cellular response. Engineered Fn 
fragments have also been shown to inhibit growth factors, control epithelial to 
mesenchymal transition. This makes Fn fragments a desirable candidate for tissue 
engineering. 
Understanding cell-integrin interactions and their role in directing cellular 
processes can be useful for tissue engineering approaches that aim to study in vitro cell 
behaviors. Further understanding how cell-Fn interactions play a role in cell behavior 
within wound healing is central to determining therapeutic targets that may aim to inhibit 
constitutive fibroblast activation leading to pathological, fibrotic disorders. Being able to 
understand the role that integrins play in fibroblast activation and in their overall phenotype 
can be useful and eventual combination with therapeutic options can provide insight for 
eventual in vivo implications that may occur. In this thesis we show how Fn’s IBD 
influences cell adhesions and cell behavior through engineered Fn fragments that have been 
previously utilized to direct endothelial phenotype and mimic the “strained” spatial 
conformation present during lung stiffening.  
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CHAPTER 2. BACKGROUND AND LITERATURE REVIEW 
 Portions of this chapter are adapted from previously published work: “Haylee 
Bachman, John Nicosia, Marilyn Dysart, Thomas H. Barker, Utilizing fibronectin 
integrin-binding specificity to control cellular responses. Advances in Wound Care. 
August 2015 4(8) pp. 501-511 Publication date: July 2, 2015 DOI: 
10.1089/wound.2014.0621”2. The author of this document contributed to this work 
primarily through overall literature review and writing of the manuscript.   
2.1 IPF and Fibrosis 
Idiopathic pulmonary fibrosis is a disease that affects roughly 200,000 Americans 
and is a terminal disorder which lacks therapeutic options that can prevent disease 
progression25,44. This disease is one of several fibrotic disorders that are characterized by 
excessive matrix deposition and tissue scarring. In this disorder the activated fibroblasts, 
termed myofibroblasts, are initiated into a wound healing process and extracellular matrix 
is excessively deposited. Connective tissue then thickens and becomes more rigid, 
triggering a positive force feedback loop and dysregulated bidirectional signaling between 
cell and matrix. In this environment the matrix deposition is uncontrolled and 
myofibroblasts will become constitutively active, leading to thickening of the matrix. Cues 
from enhanced stiffness will continue to drive the myofibroblast phenotype. It is 
understood that mechanical forces can drive biochemical signals and that the fibrotic 
matrix is providing information to cells that drives fibrosis15.  
2.2 The ECM: 
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The extracellular matrix (ECM) is an essential non-cellular component of tissues that 
is made up of protein scaffolding, which defines the extracellular microenvironment, and 
provides support to the surrounding cells31. ECM proteins provide important cues for cells 
through both composition and structure which can ultimately influence cell adhesion and 
signaling. Cells can bind via integrins, heterodimeric cell-surface receptors, which bind to 
specific sequences on their ECM proteins45,46. These interactions between cells and their 
microenvironment can ultimately direct cellular fate. Cell adhesion and signaling can be 
influenced by protein composition and structure within the ECM.  Cellular fate in the sense 
of survival, proliferation, migration, and differentiation can be dictated by the complex and 
dynamic nature of cell-ECM interactions47. Specifically, biological tissues are 
heterogeneous mixtures of various ECM proteins including collagens, laminins, 
proteoglycans and many other components which can bind and sequester growth factors 
that control spatial and sequential cellular process control.48 All of these components 
explain the complexity of the native ECM’s dynamic ability to control cell fate. This 
diverse set of constituents results in a highly complex and dynamic ECM environment that 
must be regulated to direct cell and tissue fate. 
The ECM is naturally in a state in which cells are constantly synthesizing new 
protein components and remodeling the ECM both mechanically, through deformations 
induced by cell contractile forces, and proteolytically through secretion of numerous 
proteases and new matrix molecules. Larger scale tissue composition can be impacted by 
these remodeling events to the ECM. Some lung cells, particularly fibroblasts, over-
produce extracellular matrix when they are in a strained environment which further leads 
to fibrosis. The wound healing environment is believed to be induced by breakages and 
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tears possibly due to environmental factors such as smoking or pollution. Understanding 
this environment and how we can control the activity of fibroblasts and their regulation of 
matrix proteins is imperative to expanding therapeutic treatments in this field. 
Many different ECM proteins play a pivotal role in controlling cell fate within larger 
scale tissues. During development, repair, and regeneration of epithelial tissues, cells must 
interact with the fibronectin-rich matrix of granulation tissue.39 In epithelial tissues 
including the lung, breast, and kidney, epithelial cells interact with an underlying matrix 
composed predominantly of collagen and elastin. However, in response to injury and 
during repair the matrix shifts from predominantly collagen and elastin to a provisional 
matrix composed predominantly of fibrin and fibronectin.  This biochemical shift has been 
shown to skew integrin engagement from α3β1 to αvβ3, which in turn leads to changes in 
cell behavior and phenotype.30  This matrix composition is mimicked in the lungs during 
IPF and similarly shifts integrin engagement from α5β1 to αvβ337,49. This fibronectin 
matrix may have a role in directing cells to a more migratory/repair phenotype. 
Specifically, in pulmonary tissue, the underlying vasculature is damaged and results in the 
initiation of the clotting cascade and the creation of a fibrin rich intermediate ECM with 
areas of cross-linked fibronectin.50 
2.3 Fibrosis Directed Microenvironment Changes 
These changes in the matrix result in signaling changes to the cells to direct healing 
and regeneration. Specifically, this provisional fibronectin matrix has been shown to direct 
cells to a more migratory/repair phenotype. Fibrosis Directed Microenvironment Changes 
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 The local cellular microenvironment consists mainly of the ECM but also contains 
soluble signals and substrate-bound macromolecules (ie. neighboring cells). Cells will 
consistently and continuously synthesize, assemble, and remodel the extracellular matrix. 
Cells are known to have the ability to communicate bidirectionally with the ECM by being 
both sensitive to changes in the ECM and influencing the modulation of the local ECM51. 
The inside-out and outside-in signaling is regulated by integrins. During fibrosis the 
abundance and ligand presentation of connective tissue deposited by fibroblasts changes 
creating effects on biochemical and biophysical properties of the ECM15. As shifts are 
made towards a fibrotic matrix tissue rigidity responds comparatively and tensile strain 
occurs further providing signals for disease progression.  
Pro-fibrotic cell responses occur in response to ECM stiffness. Fibroblasts 
experiencing matrix stiffening increase α-SMA expression which then constitutively 
promotes further activation of cytoskeletal features52,53. It is known that α-SMA gene 
expression is driven by MRTF nuclear localization41. Other important features such as 
cytoskeletal contractility are indicated based on pro-fibrotic changes to fibroblasts. Matrix 
stiffening also promotes fibroblast proliferation and increased matrix synthesis. This 
relationship between the microenvironment and fibroblasts demonstrates the feedback loop 
in which there is bi-directional regulation of the cell’s remodeling ECM and the sensitive 
response of the cell to its local microenvironment. During normal tissue regulation the local 
rigidity of the environment is bi-directionally regulated and when fibrotic disease is present 
the cytoskeletal-ECM adhesion complexes provide indication to the fibroblasts that they 
should activate. When the biophysical state of the ECM indicates activation of fibroblast 
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cytoskeleton the balanced relationship of this feedback loop may become unstable and 
chronic fibrotic remodeling can occur.  
2.4 Fundamentals of Integrin Binding to Fibronectin 
2.4.1 Fn Structure 
Fibronectin (Fn) is a dimeric glycoprotein containing two identical ~220kDa 
subunits that are covalently linked through a pair of disulfide bonds near their C-termini. 
Each subunit is composed of three types of repeating modules: Type I (12 modules), II (2 
modules), and III (15-17 modules) (Figure 1). Type I and Type II modules contain two 
intra-chain disulfide bridges, not present within Type III modules. Type I modules have a 
hydrophobic core made up of highly conserved aromatic residues and a disulfide bond 
which is enclosed by stacked β sheets54. Type II repeats are made up of perpendicular anti-
parallel β-sheets linked together through the previously described disulfide bonds55. Type 
III repeats are approximately 90 amino acids long and do not contain intra-chain disulfide 
bonds. These repeats are made up of anti-parallel β-sheets linked together with flexible 
loops, and only hydrogen bonding stabilizes them56,57. As a result, Type III repeats are 
highly sensitive to force-mediated unfolding58. These functional domains mediate 
interactions amongst Fn itself, with integrins, and with other ECM components. In 
particular there are 15-18 type III repeats which each are approximately 90 residues long 
and do not contain any disulfide bonds. 
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Figure 1: Modular structure schematic of full-length fibronectin molecule 
Fn is a known ligand for many integrin receptors, linking the extracellular matrix 
with the intracellular cytoskeleton. Although there are many different integrins that bind to 
Fn, the classic receptor is the α5β1 integrin receptor. Specific integrin-recognition sites 
have been identified within the Fn molecule39. Identification of integrin-specific 
recognition sites was preceded by the characterization of Fn’s interaction with cells and it 
was determined that the Fn-receptor interaction has only moderate affinity (Kd= 8*10-7 M) 
relative to other extracellular matrix protein receptors59,60. An isolated peptide sequence 
arginine-glycine-aspartic acid-serine (RGDS) has been identified as a key cell-binding site 
within fibronectin as well as a second, distant synergistic site within the cell-binding 
domain provides recognition effectively mediating adhesion and cytoskeletal 
organization61. Cellular Fn which is secreted in fibroblasts and many other cell types, is 
then incorporated into a fibrillar matrix on the cell surface. The cell-binding domain of Fn 
is comprised of an Arg-Gly-Asp (RGD) and synergy Pro-His-Ser-Arg-Asn (PHSRN) 
sequences. 
2.4.2 Background on Integrins 
Cells interact with their surrounding extracellular matrix (ECM), including Fn, via 
transmembrane cell surface receptors known as integrins.  Integrins are heterodimeric 
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proteins consisting of one α subunit and one β subunit.37. A variety of ECM protein ligands 
can be bound by integrin receptors and these are studied elsewhere62. Integrins serve as the 
link between structural intracellular protein complexes and the extracellular environment, 
effectively physically coupling the intracellular and extracellular physical network.  
The α and β subunits of integrins combine to form at least 24 unique heterodimers. 
Certain integrins can bind multiple ECM proteins, and some ECM proteins can interact 
with several different integrin heterodimers63,64. The presentation of specific adhesive 
ligands direct which integrins bind and correspondingly alter intracellular signaling 
events64. The ligand-binding sites within integrins, particularly for the ligand Fn, can be 
classified into two different groups of ligands: RGD-binding and LDV-binding type 
integrins. The active site pocket located between the α and β subunits binds ligand peptides 
and provides ligand specificity37. Integrin binding to Fn’s cell binding domain offers an 
excellent example of the complexity of controlling integrin specificity and is a continuing 
area of investigation both from the perspective of how biochemical specificity is 
determined as well as the cell biological consequences of that specificity.  
2.4.3 RGD and synergy sites in integrin binding interactions 
The major cell-binding site for many integrins is the three amino acid sequence 
arginine-glycine-aspartic acid (RGD). This tripeptide, originally identified in Fn in 1983 
by Erkki Rouslatti, is an integrin binding site present in many adhesive ECM, blood, and 
cell surface proteins65. Importantly, RGD is the primary cell attachment site for fibronectin 
binding by integrins66. Integrins that engage fibronectin via RGD include αIIbβ3, αVβ3, 
αVβ6, αVβ1, α5β1, and α8β137.  Mimicking adhesion proteins with RGD peptides has been 
a useful way to enable cell adhesion; however, RGD peptides alone are not selective for 
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specific integrins as they mimic sites in a number of adhesion proteins and are capable of 
binding to numerous different integrins66.  
The recognition of this simple tripeptide sequence can be quite complex and greatly 
depends on flanking residues, its three dimensional presentation, and individual features of 
the integrin-binding pockets For example, neighboring residues can inhibit or suppress the 
activity of RGD due to conformational restrictions that shield integrin binding67. Integrin 
binding can also be modulated by the activity of peptide sequences on neighboring 
domains. The best example of this is α5β1 integrin binding to Fn, in which RGD in 
combination with a second recognition sequence (PHSRN), the so-called “synergy” site, 
in the adjacent 9th type III repeat which when in synergy with RGD is known to promote 
the specific interaction of α5β1 integrin binding to Fn through interactions with the α5 
subunit20,21. The synergy site is located approximately 32 Å from the 10th type III repeat 
RGD loop.  The type III repeats show great elasticity in the loops between their F- and G-
β strands, known as the FG loop, which allows the 9th and 10th type III repeats to present 
multiple conformations.  Steered molecular dynamics (SMD) simulations suggest that 
under small applied forces (on the order of 10 pN) Fn’s 10th type III repeat is susceptible 
to partial unfolding, resulting in an intermediate state in which the RGD loop within the 
10th type III repeats begins to translocate away from the 9th type III repeat, resulting in an 
increase in the distance between the RGD and synergy sites from approximately 32 Å to 
approximately 55 Å58. The integrin α5β1 is the initial receptor mediating assembly of Fn 
into its fibrillar matrix. Due to the elasticity of type III repeats, the 9th and 10th type III 
repeats together present multiple conformations that direct integrin specificity to this 
region.19 Fn is known to be highly sensitive to force-mediated unfolding in which these 
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two sites can be distanced from one another.68 The best Fn unfolding model shows 
significant impact on integrin engagement and ultimately cell fate because of the domain 
unfolding of the Fn 9th and 10th type III repeats. This capacity to present multiple spatial 
orientations of the 9th and 10th type III repeats has great implications on cell binding and 
subsequent cell phenotype because the relative positioning of these two domains has been 
shown to influence integrin α5β1 binding.  Integrin α5β1 binds by simultaneously engaging 
the RGD and synergy sites and is known to be highly involved in epithelial tissue repair.  
As these sites translocate away from one another, they can no longer be bound 
simultaneously, and integrin α5β1 no longer binds resulting in changes in the normal tissue 
repair process. These results suggest that the conformation of these two domains may be 
used to drive which integrins cells use to bind Fn. For example, by stabilizing the 9th type 
III repeat by a Leu-Pro mutation at amino acid 1408, there is an increased affinity for α5β1 
over integrin αvβ3. Alternatively, by increasing the linker region between the RGD and 
synergy sites there is a reduction in α5β1 binding. Furthermore, α3β1 integrin binding to 
Fn may also be promoted by the 9th type III repeat (unpublished data). Integrins that do 
not bind the synergy site, such as αvβ3, are not affected by this separation in adhesive 
domains30. This is of particular interest because it suggests that the ratio of α5β1 binding 
to αvβ3 binding can be modulated by changing the conformation of these sites of Fn. This 
hypothesis forms the basis of Fn conformation-driven integrin specificity, and has 
significant implications in cell behavior, discussed later.  
2.5 Molecular Dynamics of the Integrin-Binding Domain 
Fn was first noted as a structurally dynamic protein by Erickson et al. in 1983. These 
researchers used electron microscopy and sedimentation analysis to observe the effect of 
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ionic strength on Fn conformation. At low ionic strength (0.05 M KCl), Fn was observed 
as a more compact, irregularly coiled strand. At increasing ionic strength (0.2 KCl), Fn was 
found to take on a more extended conformation with fewer intra-chain bends69. These 
observations suggested that electrostatic interactions influence Fn molecule conformation 
and introduced the possibility that other forces, such as mechanical tension on Fn fibers, 
may alter Fn structure as well. This discussion focuses primarily on the force-induced 
changes in the integrin-binding domain of Fn, composed of FnIII repeats.  
2.5.1 Mechanics of the FnIII domain 
About a decade later, the elasticity of another large protein, titin, was explored after 
observing that titin molecules extend up to four times their length at their I-band region. 
Titin is composed of many immunoglobulin and FnIII-like domains, and the extraordinary 
elasticity of titin is in part due to unfolding of these FnIII-like domains70. FnIII domains 
are composed of 7 β-strands arranged into 2 sheets, and are connected in series in an Fn 
molecule. Inspired by these findings, a structural model for the unfolding of FnIII domains 
was proposed in 1994 (Figure 2), but this was not directly validated on Fn fibers71. The 
comparisons to titin continued when researchers studied the intramolecular dynamics of 
FnIII10 (where the integrin-binding RGD motif is located) and an analogous FnIII-like 
domain on titin. Using 15N nuclear spin relaxation, Carr et al. found that FnIII10 is more 
flexible than the corresponding titin domain, especially on the loop containing the RGD 
sequence. At the time, these results were discussed in the context of an “induced fit” model 
for Fn-integrin binding reactions, and were used as support for the idea that the RGD motif 
on FnIII10 was not as specific to distinct integrins as the analogous RGD motif on titin 
was72. If this idea were correct, we wouldn’t expect to see specific integrins engaged with 
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Fn in different structural contexts. Yet previous work has shown that mutations affecting 
the mechanical stability and structure of FnIII9-10 can cause distinct integrins to bind73. 
An alternative explanation to these results might be that the flexibility of FnIII10 allows 
for greater mechanical sensitivity, through which Fn can tailor tension-modulated integrin 
specificity. 
 
Figure 2. Proposed model of FnIII domain unfolding by Erickson in 199471. As tension 
is applied to the relaxed molecule (A), the domains first align (B), followed by 
unfolding of certain domains (C), particularly the beta-sheet domains of the 9th and 
10th type III repeats. 
Knowledge on the molecular dynamics of FnIII domains was accelerated by the use 
of atomic force microscopy (AFM). AFM allows for single molecule measurements of 
force versus extension, providing myriad insights into the mechanical properties of fibrous 
proteins. The first protein with FnIII repeats to be investigated by AFM was Tenascin. 
Tenascin is an ECM protein important in embryonic development and tissue repair. 
Notably, tenascin contains multiple FnIII repeats along its chain. Single-molecule AFM 
was used to study the modular elasticity of tenascin, and suggested that unfolding of FnIII 
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domains was responsible for the sawtooth pattern of force versus extension curves 
observed in tenascin hexabrachions74. While this work focused on tenascin elasticity, the 
importance of FnIII domain unfolding has applications to other ECM molecules, especially 
fibronectin. The first study to specifically investigate the molecular dynamics of FnIII10 
utilized steered molecular dynamics (SMD) simulations to describe the sequence of events 
of FnIII10 unfolding and the resulting effects on RGD loop accessibility to integrin 
binding. This study predicted that the β-strand attached to the RGD loop would be the first 
to break away from the module under tension, and would therefore pull the RGD loop, 
which is normally located between two β-strands, closer to the surface of the β-sheet 
structure that comprises the bulk of the module (Figure 3). This conformational change 
was suggested to decrease the affinity of the loop for integrin receptors on the cell surface. 
The authors discussed that this property of Fn may be a mechanism of mechanosensitive 
control of ligand recognition75. Further work with SMD showed that when compared to 
other FnIII domains such as FnIII7, FnIII8, and FnIII9, FnIII10 has the lowest force 
threshold for the early stages of unfolding. This conclusion is important when discussing 
the dynamics of the integrin-binding domain since it predicts that FnIII10 will be one of 
the first domains to unfold under tension76. This simulation was later confirmed by AFM 
measurements of FnIII domain unfolding77. The incorporation of the neighboring synergy 
site in SMD simulations of FnIII10 provided a structural model for the increase in distance 
between the synergy site (PHSRN, on FnIII9) and RGD and its effect on integrin binding58. 
These simulations gave structural confirmation to earlier studies, which noted that an 
increase in the linker region between synergy and RGD led to a decrease in α5β1 binding 
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in favor of αvβ3 binding78. These findings form the basis of the theories on the 
conformational sensitivity of integrin specificity to Fn. 
Figure 3. SMD simulations of early stages of FNIII10 unfolding under force. RGD 
loop is shown in red between the F and G strands. As the G strand of FnIII10 (shown 
in (A)) is pulled (B), the RGD loop is brought closer to the bulk of the module (C). 
SMD, steered molecular dynamics. 
Simulations on the unfolding of FnIII domains were supported by in vitro 
experiments involving fluorescence resonance energy transfer (FRET). This technique 
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involves labeling fibronectin with two fluorophores: one donor, and one acceptor. 
Excitation energy from the donor fluorophore is transferred to the acceptor fluorophore, 
resulting in excitation of the acceptor. Energy transfer decays rapidly with increasing 
distance between the fluorophores, resulting in a signal that varies in strength directly with 
increasing distance. In fibronectin, the FnIII7 and FnIII15 domains are labeled with donor 
fluorophores, which encompass the integrin binding domain (FnIII9-10). The domains are 
labeled on cysteines and nonspecific labeling of exposed amino groups (lysines) with 
acceptor fluorophores so the Fn FRET probes will only indicate relative extension not 
which parts are extended; therefore, Fn FRET probe comparison across multiple batches 
cannot be compared because of the somewhat random nature of lysine labeling. This 
technique was first utilized to suggest unfolding of Fn in response to varying concentrations 
of a denaturant, and was then applied to show this effect in response to cytoskeletal 
tension79,80. Together with the SMD simulations discussed earlier, these results strongly 
suggest that cell-mediated forces can partially unfold the integrin binding domain of Fn. 
The first experimental proof proving this is evidenced in Cao et al29. 
Until recently, the existence of varying strain states in Fn fibers had not been 
observed in native tissue Previously bacterial adhesins were used to identify Fn fiber 
destruction of binding epitopes81. Therefore, phage display identified probes against 
fragments of Fn that mimic different spatial orientations of the Fn integrin-binding domain, 
peptide-based molecular probes were developed that could distinguish between “low-
strain” and “high-strain” regions of Fn fibers82. These probes were used to stain ex vivo 
mouse lung slices, and discriminate between varying strain states in the tissue83. These 
results give strong evidence to the hypothesis that distinct force-induced structural states 
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of Fn exist in vivo. It is tempting to think of the integrin-binding domain of Fn as a 
mechanically sensitive “switch” for specific integrin engagement, and the SMD 
simulations discussed earlier support this idea. Moving forward, the challenge will be 
experimental detection of the conformational changes to the integrin-binding domain that 
confirm the validity of the switch model and its relevance to mammalian physiology. 
Fn is known to be highly sensitive to force-mediated unfolding in which these two 
sites can be distanced from one another68. The best Fn unfolding model shows significant 
impact on integrin engagement and ultimately cell fate because of the domain unfolding of 
the RGD site, one of the most famous recognition sites, which is incorporated in the 10th 
type III repeat (FnIII10). This RGD loop promotes interaction via the αvβ3 subunit 
independent of the second recognition site. The second recognition sequence, 32Å away 
from the RGD loop, the “synergy site” PHSRN, is incorporated into the 9th type III repeat 
which allows these two motifs to synergistically promote α5β1 integrin binding to Fn. The 
integrin α5β1 is the initial receptor mediating assembly of Fn into its fibrillar matrix. Due 
to the elasticity of type III repeats, the 9th and 10th type III repeats together present 
multiple conformations that direct integrin specificity to this region19. 
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Figure 4. Fibronectin strain drives differential integrin affinity. PyMol structure 
predictions of engineered recombinant fragments of Fn’s integrin binding domain. 
FnIII9*10, represents a stabilized native structure through a Leu-to-Pro point 
mutation at position 1408.  In this conformation, the PHSRN-to-RGD distance is 
approximately 36 Å. FnIII9-4G-10 is a mutation of the FnII9*10 variant that contains 
a 4xGly insertion between the 9th and 10th type III repeats. This mutation increases 
domain separation and the PHSRN-to-RGD distance to approximately 43 Å.   These 
fragments have been employed in the past to predict potential biological consequences 
of the theorized integrin switch.   
2.5.2 Exposure of Cryptic Binding Sites 
It is known that specific integrin signaling is present within stiff cellular 
environments which in turn leads to enhanced fibroblast activation (i.e. enhanced 
proliferation, resistance to apoptosis, migration/invasion, and ECM synthesis). 
Concurrent with the advances in knowledge of FnIII unfolding, researchers had 
begun to investigate the process of Fn matrix assembly, which involves the polymerization 
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of multiple Fn molecules together into fibers. This process requires the accessibility of Fn-
Fn binding sites on the Fn molecule. Treatment of Fn with Fn fragments containing a 
cleaved form of the first type III repeat (FnIII-1C) was found to stimulate spontaneous 
disulfide crosslinking of Fn molecules into multimers resembling matrix fibrils. It was 
hypothesized that III-1C represented a binding site within native Fn that became revealed 
during matrix assembly84. Shortly after, another group demonstrated that heat-denaturing 
III-1 allowed for it to bind the amino-terminal portion of Fn, as in matrix assembly. The 
authors noted that since Fn matrix assembly is a cell-dependent process, the exposure of 
the Fn binding site in III-1 could result from tension generated by the cytoskeleton through 
integrin-Fn connections85. These sites, exposed through cleavage of FnIII domains, heat 
denaturation, or tension, became known as cryptic binding sites. In the following years, 
other cryptic self-association sites were discovered in Fn86. Further research into this area 
confirmed that Rho-mediated cell contractility exposes cryptic binding sites in Fn and can 
induce Fn matrix assembly. Interestingly, it was also discovered that even III-10 contains 
a cryptic binding site for III-1, and could potentially serve as an assembly site for stretched 
Fn fibrils in focal adhesions87,88. About a decade later, it was shown that tension-mediated 
exposure of cryptic binding sites on Fn leads to an increase in fiber rigidity due to increased 
Fn-Fn binding. This strain-hardening property allows Fn fibers to limit how much they can 
be extended by cell-forces, and accordingly alter local ECM environments by increasing 
fiber rigidity, which can be sensed by cells89. 
2.6 Engineering approaches to control Fn-integrin interactions 
2.6.1 FnIII9 and FnIII10 affect integrin specificity 
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It is believed that integrin specificity is related to the binding domains within Fn 
and their spatial relationships, which are controlled by the flexibility between the two sites 
of integrin binding within the FnIII9 and III10 domains. It has been directly observed that 
integrin specificity between the RGD and the “synergy” site, PHSRN, within the cell 
binding domain of fibronectin can direct cells down a migratory/repair phenotype 
necessary for wound healing processes30. These critical sites regulate epithelial cell 
phenotype by their ability to direct integrin specificity. Some ECM proteins contain the 
ability to specifically engage certain integrins, while other sequences within ECM proteins 
are known to be promiscuous for multiple integrins. It has been indicated that RGD, for 
example, engages αv integrins; however, due to the ability of several ECM proteins, 
particularly fibronectin, to be responsive to cellular and environmental changes such as cell 
adhesion and spreading forces, the distance between these two synergistic sites can have 
downstream effects on cellular expression. For example, peptides incorporating FnIII10 
only (containing just the RGD site) lead lung epithelial cells down a path of epithelial to 
mesenchymal transition (EMT); whereas, peptides including the synergy site, such as 
FnIII9-10, maintain the epithelial phenotype of the same cells. Interestingly, substrate 
mechanics play an important role in this interaction. Stiff substrates (~32 kPa) 
spontaneously induce EMT in lung epithelial cells, but this response can be overcome by 
engagement with FnIII9-10. Taken together with the studies of RGD and synergy as they 
relate to specific integrin engagement (discussed earlier in section 5.1.3), these results 
suggest interplay between substrate rigidity sensing, stiffness-mediated cell phenotypes, 
and integrin specificity43.  
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The 12th through 14th type III repeats of Fn serve an important role in the delivery 
of growth factors to cells. FnIII12-14 has been shown to bind most growth factors from the 
platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and 
fibroblast growth factor (FGF) families in the nanomolar range, without inhibiting growth 
factor activity90. Building on this finding, the Hubbell group designed Fn fragments 
incorporating both the integrin-binding domain (FnIII9-10) and the growth factor binding 
domain (FnIII12-14), along with a Factor XIIIa substrate fibrin-binding sequence as a 
method of enhancing the effects of various growth factors in wound and bone healing 
strategies91. Coupling the cell-binding and growth factor-binding domains of Fn shows 
promise in tissue engineering and wound healing approaches. 
2.6.2 Engineering Fn fragments  
Particular Fn fragments have thus far been designed to initiate desired responses from 
cells such as cell adhesion, motility, spreading, proliferation and differentiation. In 
particular, it has been noted that these ECM protein changes can engage different integrin 
“switches” which is guided by integrin specificity. These fragments have been designed 
with different length and flexibility in order to induce the desired cellular outcomes. It 
could be proposed that by engaging even more drastically different conformations there 
could be unique cellular responses that may not be as predictable.  
Small inputs of force (<100pN), within the range of cellular contractile forces, affect 
the 10th type III repeat prior to complete unfolding by exposing it to an intermediate state 
characterized by the RGD loop translocating away from 9th type III repeat. Within this state 
the RGD and synergy site distance is increased from 32Å to approximately 55Å, a distance 
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too large for both sites to co-bind the same receptor. A small cell contractile force can 
regulate this distance, or these force mediated conditions can be mimicked by engineering 
peptides that have increased linker chain length or through point mutations. These changes 
in the distance between the RGD and synergy sites have been shown to reduce α5β1 
integrin binding.78 This information suggests that α5β1 integrin binding can be mediated 
mechanically by forces that result in an intermediate lengthened state or beyond. 
Mardon et al.’s work has focused on further understanding integrin specificity within 
the cell binding domain of Fn21. This work has outlined the initial cell attachment and 
downstream cell adhesion events as significantly affected by the addition of short flexible 
linkers between the 9th and 10th type III domains. These short linkers are primarily designed 
with a series of glycine residues in order to provide a tensile character and distance between 
the two synergistic sites78. This work inspired further exploration of recombinant Fn III 9 
and 10 domains explored by Martino et al.. Engineered integrin-specific Fn fragments were 
designed from Fn’s 9th and 10th type III repeats since this is a known cell-binding domain. 
A stabilized fragment FnIII9*10 is designed with a Leu to Pro mutation which provides 
greater α5β1-integrin specificity based on the conformational stability of the RGD and 
synergy sites58,73,92,93. This recombinant Fn fragment, FnIII9*10 has a greater degree of α5 
clustering than the wild-type FnIII9-10 fragment, which due to conformational change is 
believed to contribute to specificity alternatively to the wild-type fragment, which has poor 
specificity for intergrin binding type. Another engineered Fn fragment displaying spatially 
displaced RGD and PHSRN (FnIII9-4G-10) has been explored for its preference for αvβ3 
integrin engagement. These engineered fragments can be utilized since the presence of 
force or mutational distanced type III repeats could result in preferential engagement of 
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certain integrins over others. It has been seen that ECM protein conformations affect 
integrin binding to the same protein, with different integrin binding leading to differential 
cellular responses.  
The role of alterations in Fn conformations have been explored through recombinant 
Fn fragments that were designed to model these different conformational states by mutating 
the integrin specific binding sites within the fragments. The downstream cell phenotypes 
including adhesion and spreading were investigated in order to confirm the hypothesis 
concerning the role of these conformations and their role in tissue regeneration. It is clear 
that when mechanical forces are applied to an ECM rich in fibronectin, conformation 
changes to the protein can have significant impact on integrin specificity and can in turn 
modulate cellular behavior through intracellular signaling events. It has been shown that 
through mutations within the integrin binding domains of Fn 9th and 10th type III repeats 
the conformational changes can be mimicked.  
2.7 Physiological relevance of integrin specificity  
As discussed in section 2.4.3 of this thesis, Fn can bind multiple integrins, dependent 
on the conformation of two adjacent FnIII domains. Integrin α5β1 has a high affinity for 
RGD (located on FnIII10) when the synergy site (PHSRN, located on FnIII9) is 
conformationally close. As distance between RGD and synergy increases, the affinity for 
α5β1 is decreased, while affinity for synergy-independent integrins, such as αvβ3, remains 
unchanged. As a result, Fn conformational change can drive integrin specificity. To 
illustrate the importance of this mechanism, it is useful to consider the consequences of 
integrin specificity within the context of more organized cell behaviors and even diseases.  
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2.7.1 Cell adhesion, spreading, migration, and growth 
 Evidence for integrin-specific cell behaviors was first noted in the ability of α5β1 
integrins to promote migration to a greater degree than α4β161,94. This concept was 
bolstered by research performed by the Ruoslahti group in 1993. Starting with a cell type 
that lacks the α5 subunit, Zhang et al. expressed αv subunits in these cells to obtain an αvβ1 
integrin. Cells with the αvβ1 integrin adhered to a Fn substrate, but did not migrate or 
assemble a fibronectin matrix. Transfecting the cells to produce the α5 subunit rescued 
these two behaviors95. These results were particularly striking because the β subunit 
remained the same in both heterodimers (β1), suggesting that changing one subunit of the 
integrin is sufficient to affect cell behavior. Two years later, the same group took the 
experiment one step further and showed that cells lacking α5 undergo apoptosis under 
conditions of serum starvation, whereas re-introducing α5 protected against apoptosis 
under these same conditions96. Taken together, these studies show the dramatic effect of 
integrin specificity on basic cell behavior. It is known that integrin specificity is clearly 
linked to cell fate differentiation and proliferation processes. For example, the β1 integrin 
subunit enhances the progression of differentiation of precursor cells, while αv integrins, 
like αvβ3, correlate with increased cell adhesion, enhanced cell proliferation, and decreased 
differentiation.97-100 
 About a decade later, researchers explored the effects of varying biomaterial 
surface chemistry on integrin specificity. While α5β1 integrins preferentially bound to 
surfaces rich in hydroxyl groups (-OH), αvβ3 integrins preferred surfaces with carboxyl 
groups (-COOH). Interestingly, this variation in surface chemistry not only influenced 
which integrins cells use to adhere, but also modulated the composition of the resulting 
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focal adhesion complex101. These results were strong evidence that integrin specificity 
could drive distinct cellular behaviors by altering focal adhesion composition. Integrin 
specificity has recently been shown to influence the assembly of ECM proteins such as 
collagen and fibronectin102. 
 Integrin specificity is highly sensitive to the conformation of RGD and PHSRN. 
Having identified these sequences as important for α5β1 ligation, it is tempting to reduce 
bioadhesive material design strategies to incorporate solely these two binding epitopes. Yet 
research has shown that the structural context of these sites in Fn is beneficial for cell 
adhesion, focal adhesion assembly, and cell proliferation. All of these behaviors were 
enhanced in cells exposed to FnIII7-10, a fragment of Fn containing both RGD and PHSRN 
in their native form, versus cells exposed to an RGD-PHSRN oligopeptide with a 
polyglycine linker between the two sites. Importantly, FnIII7-10 also promoted specificity 
for integrin α5β1 over αvβ3 to a much greater degree than the RGD-PHSRN 
oligopeptide103. Other work in this area has suggested that RGD-containing peptides such 
as GRGDSP can direct integrin specificity depending on the presentation of the peptide. 
Linear GRGDSP was bound primarily by α5β1 integrins, whereas binding to GRGDSP in 
a loop conformation was mediated by αvβ3104. 
The influence of recombinant Fn integrin binding domain alterations can have 
significant influence on cell fate. Fn fragments displaying stabilized synergy site, RGD 
(FnIII9'10), or RGD alone (FnIII10) can be analyzed for cell phenotype and cell-cell 
contacts. It has been indicated that epithelial cells engage integrins demonstrating the 
importance of synergy in regulation of epithelial cell phenotype behavior relevant to tissue 
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engineering as well as the use of engineered integrin-specific ECM fragments in directing 
cell phenotype.30  
2.7.2 Stem Cell Differentiation and Renewal 
 The binding of α5β1 to Fn was shown to be critical for the proliferation and 
differentiation of progenitor cells into both osteoblasts and myoblasts105,106. Using the 
biomaterial surface chemistry modification technique described in section 2.7.1, it was 
found that integrin specificity for the β1 subunit over the β3 subunit was critical for 
osteoblastic differentiation of progenitor cells107. Further studies on mesenchymal stem 
cells (MSCs) revealed similar results regarding the importance of the α5 subunit in 
promoting osteoblast differentiation108.  
 Combining these results with knowledge of FnIII unfolding events, researchers 
have engineered approaches to tailor MSC differentiation using FnIII9-10 variants with 
different mechanical stabilities. Variants that specifically promoted α5β1 binding over 
αvβ3 resulted in enhanced osteogenic differentiation of MSCs92. 
 Integrin specificity has also been explored as a method of promoting stem cell self-
renewal. By designing a defined, synthetic three-dimensional matrix, researchers 
stimulated specific combinations of integrins to promote the renewal of embryonic stem 
cells109. 
2.7.3 Wound Healing 
 The process of cutaneous wound healing involves a close coordination between 
cells and the surrounding matrix. Fn is abundantly present in the ECM of regenerating 
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injured tissues. After the initial fibrin clot forms a provisional matrix, inflammatory cells 
and fibroblasts migrate to the wound area. Fibroblasts proliferate and assemble ECM 
proteins before differentiating into myofibroblasts to contract and organize the new ECM. 
This example of matrix assembly and remodeling has the potential to expose cryptic 
binding sites, as discussed in section 2.5.2. The importance of β1 integrins in wound 
healing was first noted in keratinocyte migration during cutaneous wound repair in mice110. 
Later, the β1 integrin was found to be critical for wound closure and ECM deposition in 
cutaneous wounds5. Recently, the Hocking group designed fibronectin matrix mimetic 
proteins that preferentially engage either α5β1 or αvβ3 integrins, or an equal contribution 
of both102. Initial testing of these proteins in a diabetic mouse wound model has shown the 
capability of fibronectin matrix mimetics to promote wound healing, though the impact of 
integrin specificity is uncertain111. 
2.8 Tissue Engineering 
 To date, many groups have aimed to develop biomaterials that are capable of 
mimicking the behavior of the complex micro-environment through synthetic or 
biosynthetic hybrids for tissue regeneration applications. In order to develop new, novel 
biomaterials, this dynamic environment must be further explored to ultimately lead to 
therapeutic options for tissue regeneration.112 . Development of model systems used to 
investigate cell behavior and fate under a multitude of different environmental conditions 
is of particular interest. 
Integrin-specific peptide sequences are an obvious candidate for tissue engineering 
approaches, due to their ability to modulate cell behavior. One example of these approaches 
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is the use of FnIII7-10, an α5β1-specific fragment, as a coating on titanium bone implants 
to improve osseointegration113.  Augmentation of bone regeneration has also been achieved 
by delivering bone morphogenetic protein-2 (BMP-2) in a hyaluronic acid hydrogel 
modified with FnIII9*-10, a fragment known to bind α5β1114. 
Biomaterials that are capable of mimicking the behavior of desired environments 
in synthetic or biosynthetic hybrids have been a desired goal in the field of tissue 
engineering and regenerative medicine. Specifically, during tissue development, repair, 
and regeneration of epithelial tissues; cells must interact with the structural scaffold of 
tissues comprised of a fibronectin (Fn)-rich matrix39. For example, in the case of wound 
healing, biochemically the ECM is known to shift from a predominantly laminin/elastin 
matrix to the emergence of a provisional matrix majorly comprised of fibrin and 
fibronectin. This shift leads to changes in cell behavior and phenotype. This concentrated 
Fn matrix may aid in directing cells to a more migratory/repair phenotype. Specifically, in 
pulmonary tissue, underlying vasculature is damaged and results in the initiation of the 
clotting cascade and the creation of a fibrin rich intermediate ECM with areas of cross-
linked fibronectin. Controlling cell behavior within engineered tissues is essential for tissue 
repair and regulation mechanisms for organ function. Cellular process left uncontrolled 
that enhance the progression of fibrosis can be an ideal candidate for regenerative medicine 
strategies. Mechanical signals influenced by matrix rigidity are known to drive fibrosis but 
it is important to explore these effects in combination with biochemical cues provided in 
strained matrices as well. Exploration into potential therapeutic inhibitors of certain cell 
processes could be useful in limiting the progression of fibrotic disease, particularly IPF. 
2.9 Mechano-transduction 
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Mechano-transduction is a sensory transduction mechanism by which cells sense and 
respond to mechanical stimuli by translating into electrochemical biochemical signals that 
can prompt specific cellular responses. As cells secrete, assemble, and remodel their matrix 
the biophysical properties of the matrix can alter based on stiffness, binding site 
conformation, and other crosslinking properties. As these properties change a feedback to 
cell response is mediated through cell signaling which can then further create a force-
feedback loop115. These effects can result in cell functions like proliferation, resistance to 
apoptosis, adhesion, cytoskeletal structure, cell contractility, and motility116. Cells will 
remodel themselves and their environment based on different cell-ECM force signals117.  
Integrins are implicated in sensing mechanical forces at site between the cell and 
ECM at a physical attachment site, integrin-based adhesion64. Integrins are 
mechanosensitive and take mechanistically relevant information into the cell. The physical 
association between cytoskeleton and ECM, focal adhesions, can propagate biochemical 
signals and is dynamic in response to mechanical force118,119. Complexes around focal 
adhesions which are scaffolding molecules such as paxillin and vinculin can provide 
information about the maturation of these adhesion complexes120-122. Mechanical tension 
at the sites of these adhesion complexes can lead to activation of downstream signaling 
molecules such as focal adhesion kinase (FAK), Src, and others123,124. As focal adhesions 
assemble following ECM ligation of cells other integrin-specific signals can be paved and 
exogenous force applied at these sites can mimic signals generated by internal force. 
Cytoskeletal rearrangements can result in site specific stiffening of the cell at the cell-ECM 
adhesion sites125. Cryptic binding motifs may be exposed as force alters the matrix which 
may change the downstream signaling pathways associated with carious structural FA and 
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cytoskeletal proteins (ie integrin) leading to signal transduction126,127. The multifaceted 
architecture and abundance of proteins, and binding interactions make the study 
mechanotransduction perplexing although key for understanding the relationship of 
mechanical stimuli to biochemical signal. 
Key focal adhesion components are analyzed in this work. Src family kinases 
(SFKs) are a grouping of nine related tyrosine kinases with homology to c-Src128.  It is 
known that the simple regulation of integrin clusters (when ligation or force is absent) 
downstream signaling molecules necessary for signal generation such as SFKs are 
recruited129. Alternate scaffolding molecules are necessary to bridge the interactions 
(binding) between early signaling intermediates and integrin receptors.  Adaptor proteins 
that bind to the β-integrin cytoplasmic tail are outlined in Legate et al. and it is previously 
known that Src binds β3 and FAK binds β1 and β3 which should ultimately have an effect 
on downstream events important for phenotype130,131. 
Adhesion-associated signaling molecules such a FAK and Src play a critical role in 
integrin signaling a focal adhesion formation. Shattil et al. work shows that Src Family 
Kinases (SFKs) play a critical role in adhesion assembly and integrin-mediated regulation 
of multiple downstream pathways such as FAK and Src and corresponding 
phosphorylation129,132. The mechanosensitive signaling molecule FAK is activated in 
response to force. The complex formations of SFKs with previously activated FAK results 
in phosphorylation of additional tyrosine residues in FAK serving as a binding site for 
subsequent proteins129. Examples of how enhanced ECM deposition and crosslinking via 
fibroblasts enhances integrin signaling in nascent cells through extracellular-related kinase 
and focal adhesion kinase is explored in mammary tumorgenesis through work by Levental 
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et al133.  Modulation of intracellular signaling pathways via SFKs (ie. Src and FAK 
explored in this work) can be critical for fibroblast phenotype both in vitro and in vivo 
(Figure 5). Fn-binding integrin-associated SFK, c-Src is also fibroblast expressed so 
understanding the relationship between the Fn IBD and the downstream effects on 
signaling can be key to interpreting phenotype changes.  
Figure 5. Schematic of FAK and Src phosphorylation and output on cell behavior. 
2.10 Myofibroblast Characterization 
Fibroblasts are a type of cell which synthesize, assemble, and remodel the protein 
matrix that make up the stroma of connective tissues. Fibroblasts can be defined as cells 
that create a meshwork of structural (collagen and fibronectin) and nonstructural 
(matricellular molecules) ECM molecules through synthesis and secretion. These cells will 
also organize and remodel the ECM with proteinases they produce. These fibroblast cells 
will also interact with neighboring cells through autocrine, paracrine, and other forms of 
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communication134. Mechanotransduction also helps to define fibroblasts through their 
ability to respond to directional cues within their local mechanical environment. 
Fibroblasts sense mechanical stress and translate this information into the remodeling of 
the ECM. Understanding the mechanism of this adaptive process is imperative for the 
future of tissue regeneration and engineering designs.  
In IPF the presence of myofibroblasts, activated fibroblasts, are located at 
fibroblastic foci and are indicated by expression of α-smooth muscle actin135. It is known 
that within the alveolar wall myofibroblasts will proliferate and deposit ECM furthering 
disease progression. As fibroblasts are native to healthy lung tissue it is important to 
diagnose the unique phenotypic differences responsible for IPF versus the normal 
pathological features associated with essential normal lung repair136,137.  Myofibroblasts 
continue to drive the fibrotic nature of disease because their functional role in IPF is the de 
novo assembly of fibrotic tissue. It is noted in other work that fibroblasts noted in IPF 
display a unique phenotype that is still uncharacterized136,137.  Since fibroblasts in the lung 
are both responsible for and sensitive to changes towards IPF understanding how 
fibroblasts sense and respond to changes in the ECM. Activated fibroblast can be 
characterized by their increased cytoskeletal contractility, the upregulation of genetic 
biochemical signals that support this cell contractility, expression of α-SMA, increased 
proliferation, migration/invasion, increased ECM synthesis, and resistance to apoptosis138-
140.  
Unanswered questions about which events are triggered in normal human lung 
fibroblast that may lead to fibrosis is further explored in this thesis. Characterizing the 
shifts in phenotype based on biochemical cues and the integrin associated events that may 
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lead to these changes will be addressed. Identification of the “integrin-switch” in normal 
human lung fibroblast when they are presented with engineered variations of Fn’s IBD and 
focal adhesion components associated with such events in the presence of force are 
explored. Classification of the fibroblast to myofibroblast phenotype changes is observed 
by analyzing myo-type phenotype indicators like α-SMA expression and MRTF nuclear 
translocalization. The data in this review will cover these unanswered question by 
establishing a process for which engineer Fn fragments can be optimally produced and then 
further used to understand the relationship between Fn IBD spatial presentation and lung 
fibroblast cellular response.  
2.11 Summary 
To summarize; this comprehensive examination discussed fibrosis and IPF, the 
ECM, the microenvironment and fibrotic progression, integrin binding to Fn, molecular 
dynamics of the integrin binding domain, engineering approaches to control Fn-integrin 
specificity, physiological relevance, mechanotransduction, and the characteristics of 
myofibroblasts. Fibrotic disease lacks many options for treatment. Since the space around 
the ECM and fibroblast interaction has limited understanding it is important to continue to 
explore the phenotypes associated with fibrosis. It is also useful to expand the knowledge 
of the bidirectional mechanotransduction and how it becomes uncontrolled within fibrotic 
tissue. Investigating the biochemical and biophysical relationship between the matrix and 
fibroblasts is of great importance to better understand how fibrosis occurs and what 
therapeutic options there could be for the treatment of these disorders and of particular 
interest to us IPF.   
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CHAPTER 3. ENGINEERED SYSTEM FOR FIBRONECTIN 
FRAGMENT EXPRESSION, PRODUCTION, AND 
PURIFICATION 
Portions of this chapter are adapted from previously published work: “Shuoran Li, Lina 
Nih, Haylee Bachman, Peng Fei, Yilei Li, Eunwoo Nam, Robert Dimatteo, S. Carmichael, 
Thomas Barker, and Tatiana Segura, Hydrogels with precisely controlled integrin 
activation dictate vascular patterning and permeability. Nature Materials. July 12, 2017 
DOI: 10.1038/nmat4954”141. The author of this document contributed to this work 
primarily through contribution of FnIII9-10 variants, optimization of protein expression 
system and writing of the manuscript. 
Portions of this chapter are adapted from previously published work: “Haylee 
Bachman, John Nicosia, Marilyn Dysart, Thomas H. Barker, Utilizing fibronectin 
integrin-binding specificity to control cellular responses. Advances in Wound Care. 
August 2015 4(8) pp. 501-511 Publication date: July 2, 2015 DOI: 
10.1089/wound.2014.0621”2. The author of this document contributed to this work 
primarily through overall literature review and writing of the manuscript.   
3.1 Introduction 
Fibronectin (Fn), an EMC protein, is a good candidate for exploring the wound healing 
processes. The Fn molecule is a high molecular weight (~440kDa) glycoprotein that 
participates in a wide array of important cellular interactions such as adhesion, migration, 
growth and differentiation. Fibronectin is an essential component of the provisional matrix 
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and is a template for collagen deposition. Typically Fn is purchased for a high price from 
a life science retailer or through an extensive process it is isolated from human plasma. 
After decades of investigation of the complexity of the full-length Fn, various binding sites 
and interaction motifs are indicated contributing to its intricate nature. Another key 
difficulty results as aggregation of this large molecule occurs during the purification 
process. These components indicated the difficulty of using full-length protein even though 
it’s an attractive option for creating bio-functional surfaces for cell adhesion and regulation. 
The complex nature of this molecule and the desire to specifically engage a specific 
interaction to determine site-specific makes a clear argument for using recombinant 
proteins to mimic the integrin binding site. 
In Martino et al. isolated fragments containing the integrin binding domain of Fn was 
isolated and manipulated for further studies92. This region is of particular interest because 
the effects that integrin signaling has on cell phenotype would be indicative to therapeutic 
targets that aim to inhibit the fibrotic process. Using the integrin binding domain (located 
within Fn’s 9th and 10th type III repeats) we can observe very distinct influences that are 
guided by differential integrin engagement. Further these recombinant Fn fragments can 
be used specifically to present biochemical cues that mimic strained and relaxed Fn 
conformations. Previously, the Barker Lab designed several Fn mimics based on the 
understanding of Fn unfolding (founded on MD simulations from Erickson et al.71). Small 
inputs of force (<100pN) affect the 10th type III repeat prior to complete unfolding by 
exposing it to an intermediate state characterized by the RGD loop translocating away from 
the 9th type III repeat (containing PHSRN “synergy” site). Within this state the RGD and 
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synergy site distance increases from 32Å to roughly 55Å, a distance too large for both sites 
to co-bind the same receptor.  
While cell contractile forces can regulate this distance between FnIII9 and FnIII10 in 
vitro and in vivo, these force mediated conditions, FnIII10 extended from III9 and FnIII9-
10 together, can be mimicked by engineering peptides that have increased linker chain 
length or through point stabilizing point mutations, respectively.  
Integrins are heterodimeric cell surface receptors that link the cytoskeleton of a cell to 
the ECM with at least 12 distinct integrin pairs capable of linkage to Fn142. Integrins are 
well-studied receptors for Fn and they play a critical role in the assembly of Fn into fibrils 
within the ECM143.  Fn matrix assembly into Fn fibrils is regulated by α5 and αv integrin 
subunits even though other subunits can regulate ECM protein secretion144. The integrin 
α5β1 is the major Fn binding integrin that cells use to engage and assemble Fn molecules 
into the matrix145,146. These two key studied Fn-binding integrins, α5β1 and αvβ3, both 
engage the RGD recognitions motif within FnIII10. However, α5β1 can also engage the 
PHSRN “synergy” site within FnIII9, presumably by binding to the α5 subunit and altering 
its conformation, for high affinity Fn-integrin interactions92,147.  Recent evidence suggested 
that integrins α5β1 and αvβ3 can work together to optimize fibroblast rigidity sensing on a 
Fn-based substrate, and may have implications for cell migration and invasion in fibrotic 
pathologies and cancer148. It was hypothesized that spacing between the RGD and PHSRN 
site may result in differential integrin engagement and potentially mediation of different 
signaling events. Because of this hypothesis, recombinant fragments were designed which 
mediated the molecular conformation of the FnIII9-10 region to mimic force-actuated 
changes. 
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Recombinant fibronectin fragments of the 9th type III repeat (FnIII9) and 10th type III 
repeat (FnIII10) were designed to preferentially bind α3/α5β1 or αvβ3 integrin 
respectively. The mutation, FnIII9*10, has been previously shown to stabilize the integrin-
binding domain of fibronectin and enhance its binding selectivity to synergy-dependent 1 
integrins, including both 51 and 3192,149,150. To achieve αvβ3 integrin specificity, 4 
glycine residues were then inserted into the linker region between FnIII9 and FnIII10 
(mutation called FnIII9-4G-10)43.  The 4 glycine insertion (FnIII9-4G-10) both physically 
separates the synergy (PHSRN) and RGD sites located on FnIII9 and FnIII10, respectively, 
and introduces torsional flexibility between the two domains, resulting in a complete 
disruption of α3/α5β1 integrin binding and promoting a αvβ3 integrin preference. These 
changes in the distance between the RGD and synergy sites have been shown to reduce 
α5β1 integrin binding.78 Though both recombinant fragments can theoretically bind αvβ3 
integrin via the RGD sequence, we and others consistently observe a preference of the 
stabilized mutant (FnIII9*10) to bind synergy-dependent integrins, like α5β1 
integrin30,43,141. This information suggests that α5β1 integrin binding can be mediated 
mechanically by forces that result in an intermediate lengthened state of FnIII9-10 or 
beyond. Through previous work indicated FnIII9*10 is believed to mimic a relaxed integrin 
binding domain of Fn and FnIII9-4G-10 mimics the strained matrix environment. These 
Fn fragments are a useful way to explore the cell phenotypic responses specific to integrin 
engagement with ECM protein fibronectin. 
These previously developed recombinant fragments of Fn’s integrin binding domain 
that mimic the predicted “relaxed” and “strained” states and, within this dissertation, their 
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use to probe important wound healing phenotypes of fibroblasts, such as proliferation, 
mechano-transduction and myofibroblastic differentiation will be further explored.  
 In Brown et al. epithelial cells were found to engage RGD only with αv integrins 
demonstrating the importance of synergy in regulation of epithelial cell phenotype behavior 
relevant to the use of engineered integrin-specific ECM fragments in directing cell 
phenotype30. Consideration of similar effects for fibroblasts due to their known activation 
and known myofibroblast differentiation during the wound healing process is relevant. 
Within IPF there are specific myofibroblast-like phenotypes such as excessive matrix 
deposition (lung architecture remodeling), resistance to apoptosis, and increased 
contractility, spreading, and motility. These could be related to the changes seen in integrin 
binding because various integrins can promote different activities within the cell. This 
relationship between integrin engagement and myofibroblast phenotype in human lung 
cells hasn’t been directly explored up until this point. Through previous work it has been 
indicated that differential integrin engagement occurs when cells are exposed to these 
recombinant Fn fragments (FnIII9-10). These fragments need to be produced efficiently so 
that they can be used to probe these phenotypes easily by presenting variable conformations 
that may trigger integrin selectivity that ultimately influences to downstream cell behavior. 
Using these fragments that solely contain the Fn integrin binding domain, we are able to 
attribute differences that are observed to the integrins that we recognize as being engaged 
with each fragment respectively. 
The FnIII9-10 constructs were originally highly susceptible to plasmid mutation and 
overall plasmid and peptide degradation. Issues with mutations to the DNA, nt-sequence 
and low copy number have caused alterations in protein expression levels as well as 
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misfolding and incorrect protein expression. These mutations cause chronic issues with 
production, purification, and use for cellular experiments. Metabolic stress is exerted on 
the bacterial cells as they are engineered to express recombinant proteins; therefore, careful 
consideration of plasmid design is necessary to reduce the many difficulties seen within 
the original expression platform. Through freeze-thaw cycles and generation expansion, 
these previously engineered constructs lost viability and production/quality was unreliable; 
therefore, an improved construct was designed to maximize protein expression, allow for 
ease of protein tracking, and improve the purification process. Optimization was completed 
to produce maximal amounts of protein. Various growth temperatures were explored due 
to the temperature effect on growth rate of the bacteria and this facet could be easily 
optimized. Media conditions can provide different ratios of amino acids, sugars, and other 
nutrients for cells so it is useful to maximize expression of proteins but evaluating various 
mediums for growth. Induction regulator (IPTG) concentration can be maximized for peak 
induction rate and total amount.  Careful consideration to the design of the engineered 
protein was given and new strategies were outlined to monitor the quality of each batch of 
protein after purification.  
3.2 Materials and Methods 
3.2.1 Redesign Protein Expression Plasmid 
Engineered, recombinant Fn fragments were designed to observe the integrin binding 
domain (9th and 10th type III repeats) and the effects they can have on cell signaling. Two 
specific recombinant peptides were observed that can provide different cell signals based 
on the integrins they engage. The original protein production process used was inefficient 
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due to dysregulation of cell metabolism causing DNA mutations; therefore, the system was 
re-engineered in order to optimize protein expression and simplify the purification process. 
The expression system for these recombinant Fn fragments was optimized from prior 
publications (Markowski et al.) to create a high throughput production process43. New 
plasmid constructs were designed with new multipart features added. A 10-His tag was 
added on the C-terminal end and is used for purification in an AKTA start system. A 
thrombin-cleavable tdTomato fusion protein for real-time production feedback and 
optimization of protein production conditions was also included (Figure 6).  
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Figure 6. Vector Maps of FnIII9*10 and FnIII9-4G-10. Indicated are the design 
elements of significance for expression and purification purposes (recombinant changes 













































































Figure 7. List of nucleotide and protein sequences for FnIII9*10 and FnIII9-4G-10 
engineered fragments. 
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The original expression constructs were susceptible to metabolic stress and often 
resulted in DNA mutations eventually affecting the expression rate/sum or peptide 
constructs. These mutations can influence 3D structure causing increased aggregates or 
expression of the engineered protein into inclusion bodies. The problems of this original 
expression system resulted in difficulty in purification and eventually ineffective protein. 
Decisions were made for designing the vector which include creating a better regulating 
unit lacO to be induced with IPTG and this control reduces the metabolic stress on the 
bacterial cell allowing for more regulation of expression and maximized cell growth and 
control resulting in maximal protein expression. 
The cloning techniques used for design are outlined in Bryksin et al. for insertion of 
RBS as well as similar techniques used for insertion of other design features151. Translation 
efficiency is described in this work as well and is applied here where it is important to the 
overall design for maximum expression and optimized production. 
The expression system for these recombinant Fn fragments was optimized from prior 
work and high throughput production was the goal. Other design features were included 
for application with cellular assays and other basic biological observations of the fragment 
influences on cell behavior and fate. For ease of immobilization onto surfaces and 
incorporation into natural and synthetic hydrogel biomaterials both fragments were 
produced with an N-terminal cysteine residue to allow Michael type addition modifications 
and a factor XIIIa substrate sequence, consisting of residues 1–8 of the protein alpha2 
plasmin inhibitor (α2PI1-8, NQEQVSPL)
152 to allow enzymatic conjugation141. 
3.2.2 Optimize Expression 
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The fusion-reporter design of the bacterial expression vector allows for protein 
production to be monitored in real time via the presence of tdTomato fusion protein. 
Optimization of growth conditions were explored by varying conditions such as media 
composition, growth temperature, induction concentration, and growth timing. 
Plasmid constructs were transformed into MDS™42 LowMut ΔrecA chemically 
competent bacterial cells from Scarab Genomics. After transformation, a colony was 
expanded and then frozen down with 7% DMSO as a bacterial stock.  
A 100mm LB/Agar plate with 50µg/mL Kanamycin was streaked with bacterial frozen 
stock of desired protein vector. Colonies were grown on LB/Agar plate overnight in 
incubator at 37°C. Colonies were picked for starter culture by adding 5mL of media (TB, 
2xYT, SOB, or Korz) with 5uL of stock antibiotic Kanamycin (50µg/mL) in a 10mL tube. 
Each starter culture was grown overnight at 37°C with shaking. Cultures were then diluted 
to OD600 approximately 0.4 and grown to OD600 0.8 at 37°C with shaking. Cultures were 
transferred to a 96 well plate with different starter cultures (in triplicate) and to have 
different induction (via IPTG) concentrations added. IPTG concentration range included 
0.25mM, 0.5mM, 1mM, and 1.5mM. Beginning at 24 hours, expression was monitored on 
BioTek Synergy H4 Microplate Reader with shaking at temperatures 22.7°C and 25°C. 
Expression levels were monitored via tdTomato expression fluorescence tracking at 
excitation 554nm, emission 581nm.  
Individual clones were picked and used for subsequent expansion and increased protein 
yields. 1L of 2xYT media is prepared and autoclaved (Liquid Cycle for 30 min at 121°C) 
for sterility. 2.5mL of 2xYT media was distributed across four 10mL sterile culture tubes. 
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Antibiotic (Kanamycin) was added at 50µg/mL from stock. 100uL bacterial stock 
previously frozen at -80°C with 7% DMSO added to each tube. Cell density of stock was 
unknown so optical density was monitored. Incubated starter culture at 37°C for ~3 hours 
then added this starter culture to 250mL of 2xYT media in 1L flaks. Closely monitored 
OD600 (blank with 2xYT media) for ~ 2 hours until OD600 was roughly 0.8-1.2 then induced 
cultures with 1.5mM IPTG and incubated overnight (~16 hours) with shaking in incubator 
at 37°C. Tdtomato was visibly apparent after overnight expression for maximal protein 
production and bacterial culture appears “pink-ish” in color (Figure 8). Cells are pelleted 
via centrifugation at 4000 x g for 10 minutes at 4°C. The supernatant was discarded and 
“pink” cell pellet was then resuspended in protease inhibitor in 45mL of 1x PBS141. Cells 
were then lysed by addition of 10mg/mL lysozyme (in 25mM Tris-HCl pH 8.0). Cells were 
then sonicated on and off for 20 seconds each for a total of 1 min and 20 seconds on. Triton 
X-100 at 1% and 10U/mL of DNAse was added to each sample. Samples were shaken for 
30 minutes in the cold room and then frozen overnight (minimum) at -20°C and then 
thawed. At this point the release of subcellular components should have occurred through 
mechanical disruption forces, high frequency sound waves, and freeze/thaw cycling. 
Proteins are consistently stored on ice to avoid protein denaturation and aggregation. 
Samples were then spun down (12,000 x g at 4°C for 15 minutes) to remove cell debris and 
isolate soluble proteins in supernatant. Soluble protein supernatant (pink if lysis was 
effective) can then be filtered through a 0.22 µm pore filter.  
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Figure 8. Purified FnIII9’10+tdTomato+His10. Purification of protein can be tracked 
through observation of pink color from tdTomato fluorescent protein which is 
downstream from the FnIII9’10 protein and upstream from the His10 tag protein. 
3.2.3 Detailed Purification Process 
Recombinant FnIII9-10-tdtomato-His10 proteins were purified on a HisTrap FF 
nickel column (ÄKTA Start, GE Healthcare) via affinity chromatography using Unicorn 
1.0 Method Editor. Up to three 5mL prepacked columns were daisy chained together to 
maximize protein binding for each culture. Binding buffer (20mM sodium phosphate, 0.5M 
sodium chloride, 25mM imidazole, pH 7.4) and elution buffer (20mM sodium phosphate, 
0.5M sodium chloride, 0.5M imidazole, pH 7.4) was used for washing and elution steps 
based on affinity release on a nickel column. Protein was monitored at this step by 
observation of fluorescent protein, tdTomato, as the protein bound to the column and then 
subsequently eluted. At each step the peptide was tracked as it went into the collected 
fractions based on the fractions that contained a pink color. Peptide was buffer dialyzed 
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(just buffer exchange for second run so that the peptide doesn’t run through the column 
due to high imidazole concentration) in 1x PBS overnight at 4°C using a 10kDa snake-skin 
tubing. The fusion protein, tdTomato, and 10-His affinity tag were removed from FnIII9-
10 fragments by utilizing the thrombin cleavage site and bovine thrombin (Sigma-Aldrich, 
20U/mg of protein, room temp 1 hr or overnight at 4°C) and was often done in combination 
with the previously mentioned dialysis step to separate the fragment and the tdtomato 
fusion protein (See Appendix Figure A1). A Benzamidine FF column (GE Healthcare, Life 
Sciences) bound the free bovine thrombin and the His tag allows collection of C-terminal 
tdtomato in the HisTrap FF column again and the Fn fragments (FnIII9*10 or FnIII9-4G-
10) were released. Gel Filtration was completed on size exclusion column (GE Healthcare, 
HiLoad 16/60 Superdex 200 prep grade) to separate protein dimer and monomer (break 
disulfide bonds of dimer with immobilized TCEP disulfide reducing gel). Isolated protein 
of molecular weight ~20kDa is likely the desired FnIII9-10 fragment. Protein presence in 
each fraction was validated using SDS-PAGE.  
3.2.4 SDS-PAGE 
Fractions collected were analyzed via SDS-PAGE and nanodroped (Thermo Fisher 
NanoDrop), to determine protein presence and concentration. MicroBCA assay (Thermo 
Fisher Scientific) was also used to verify concentration. Purified, denatured/reduced 
proteins and Precision Plus Protein All Blue Prestained Protein Standard (1610373) were 




In a competitive ELISA assay experiment, 96 well plates were coated with purified 
proteins at the specified concentrations diluted in 1x PBS overnight at 4°C. Washes with 
PBST (0.1% Tween-20 in PBS) removed unbound protein and then well plates were 
blocked with MPBS (2% wt/vol nonfat dry milk in PBS) for 30 minutes at room 
temperature on an orbital shaker. Bound proteins were then detected using a primary 
antibody. One plate was coated with the phage isolated H5 antibody (100ng/mL), which is 
known to contain a myc-tag, and a control plate was incubated with the primary antibody 
HFN 7.1 (1:2000, Thermo Fischer, MA5-12314), a monoclonal mouse antibody to the 
integrin-binding domain of Fn. The plates were then coated with an anti-myc biotin 
(1:2000, Sigma Aldrich, B7554) or anti-mouse biotin (1:2000, abcam, ab97044) 
respectively. These steps were followed by HRP conjugated extravidin (1:1000, Sigma 
Aldrich, E2886). One-step Ultra TMB (3,3',5,5'-tetramethylbenzidine) ELISA substrate 
was used to complete the assay (Thermo Fischer, 34028). Absorbance readings were read 
at 450nm on a BioTek Synergy H4 microplate reader and blank wells were subtracted so 
that relative protein concentration could be determined. 
3.2.6 Dot Blot 
Purified proteins were spotted in duplicate (5µL each dot) at indicated 
concentrations onto a nitrocellulose membrane and given time to dry. The dot blots were 
then blocked with MTBS (5% wt/vol nonfat dry milk in 1xTBS) at room temperature for 
one hour then incubated with H5 or HFN 7.1 (1:6000) overnight at 4°C on a 3D rocker. 
The H5 dot blot was then incubated with an anti-myc mouse monoclonal antibody (1:6000, 
Thermo Fischer, R950-25). Both dot blots were then incubated with a LI-COR goat anti-
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mouse IR dye 800CW (1:15000, LI-COR, 926-32210). Imaging of the dot blots was 
completed with a LI-COR scanner. 
3.2.7 Western Blot 
Purified, denatured/reduced proteins and Precision Plus Protein All Blue Prestained 
Protein Standard (1610373) were separated with a 10% SDS gel through SDS-PAGE and 
transferred to a nitrocellulose membrane where the blot was then cut to allow for separate 
staining. The western blots were then blocked with MTBS (5% wt/vol nonfat dry milk in 
1xTBS) at room temperature for one hour then incubated with H5 or HFN 7.1 (1:6000) 
overnight at 4°C on a 3D rocker. The H5 blot was then incubated with an anti-myc mouse 
monoclonal antibody (1:6000, Thermo Fischer, R950-25). Both blots were then incubated 
with a LI-COR goat anti-mouse IR dye 800CW (1:15000, LI-COR, 926-32210). Imaging 
of the blots was completed with a LI-COR scanner. 
3.2.8 Attachment assay 
Cell attachment assays were performed as previously described153. Briefly, surfaces 
were coated with 2µM Fn fragments (FnIII9*10 and FnIII9-4G-10 have similar coating 
efficiencies) or 10µg/mL full length WT Fn and blocked with 1% hd-BSA92,154. CHO.K1 
express only α5β1 integrins and CHO.B2 cells express only αvβ3 integrins. Cells were 
seeded at 20,000 cells/well and were allowed to attach for approximately 20 minutes at 
37°C in 10%-serum F12-K media then washed to remove unbound cells, fixed with 5% 
glutaraldehyde, and stained. A 0.1% crystal violet solution was used to stain the cells. After 
drying the stain was solubilized with 10% acetic acid and absorbance was quantified on 
the BioTek H4 Microplate Reader at 570nm. Linear regression was performed on the 
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standard curve to determine reliability of the assay. Attachment values were normalized to 
cell attachment levels hd-BSA (0% attachment). Data from the triplicate experiment was 
normalized to the cells remaining in the highest cell density wells from the standard curve 
and presented as average +/- standard error. Normalized remaining cell percentage is 
presented on the y-axis. 
3.3 Results 
3.3.1 Optimized Expression 
During protein expression optimization the fusion protein fluorescent tdTomato was 
monitored as a sign that protein was produced. The downstream location of the tdTomato 
indicated that if tdTomato folded properly and reveals a fluorescent protein then we could 
assume that the upstream FnIII9-10 fragment had been produced as well (Figure 9).  
Figure 9. Basic outline of FnIII9-10 expression profile. This schematic highlights the 
important features from protein expression designed for these engineered Fn 
fragments. The lacO is associated with IPTG inducible control. FnIII9’10 represents 
the Fn fragment that is desired. The thrombin digest site allows for cleavage of the 
tag proteins for complete purification. tdTomato is the fluorescent protein associated 
with the expression system to track production and allows for ease in optimization 
and purification tracking. The His10 represents the 10 consecutive Histidine residues 
used to tag the protein for affinity chromatography in a nickel column.  
Here we observed the expression of tdTomato over 24 hours after induction under 
variable conditions (media variations, and IPTG concentration) (Figure 10). This 
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experiment was performed at different expression temperatures as well, in order for us to 
get a sense of which conditions would be best for maximal protein production and 
convenient, efficient, cost effective optimized process. From this process we chose good 
condition candidates in order to scale up. The chosen conditions were 2xYT media, at 30°C 
for overnight expression after 1.5µM IPTG induction. These conditions were chosen 
because their efficiency but also with consideration to ease of use, access, cost and 
experimental timing. This protein expression optimization scheme is capable of generating 
~20 mg/L of protein within the culture prior to purification.  
 
Figure 10. Fluorescent protein tracked for optimization of purification. Conditions of 
growth were eventually chosen based on results from these optimization results, 
convenient times, and inexpensive reagents.  
3.3.2 Purity Identification 
The purity of FnIII9-10 protein fragments was analyzed by SDS-PAGE as 
mentioned in previous works30,92. Analysis of proteins at varying stages of the purification 
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process is important to understand if your product is pure or if there is major loss of protein 
at other steps of the process. 
Molecular weight of ~20kDa is seen in SDS-PAGE results (Figure 11). Observation 
of the changing concentration as fractions are run through the column. The thrombin digest 
is visible on SDS-PAGE as well. 
Figure 11. SDS-PAGE analysis to observe purification of FnIII9*10 fragment. Lane 
1 shows the H5 scFv phage-based antibody fragment (MW ~28kDa). Lane 2 is the 
Bio-Rad Precision Plus Protein All Blue Standard. Lane 3 indicates the thrombin 
digest and identifies the individual halves digested by thrombin and the presence of 
thrombin (Thrombin MW ~36kDa and FnIII9*10 MW ~20kDa). Lane 4-7 show 
purified FnIII9*10 after thrombin digest (MW~20kDa) and a second run through the 
column which washes out purified protein. Lane 8-9 show that proteins that were 
bound to column after thrombin digest which includes tdTomato+His10 
(tdTomato+His10 MW ~32kPa). 
Size Exclusion Chromatography (SEC) is used to separate based on size, larger 
proteins will elute first and smaller proteins will elute later. A calibration kit is run to 
compare elution time with approximate protein size. Gel filtration validates size after 
calibration which indicated dimer and monomer configurations (Figure 12). It is 
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determined with the analysis of the gel filtration column run that there is typically 1.1:1 
(12:11) ratio of dimer to monomer concentrations respectively. These dimeric units are not 
visible on a denaturing SDS-PAGE gel due to reducing agent added therefore this is the 
best way for different size proteins to be identified. 
 
Figure 12. SEC of purified FnIII9-4G-10 fragment dimer and monomer. Monomer 
unit can either be isolated based on fraction or further reduction of di-sulfide bond 
can be used to reduce dimer to monomeric form. 
The dimer product can be treated with Immobilized TCEP Disulfide Reducing Gel 
(Fischer Scientific) to reduce di-sulfides that link monomer units together to form the 
dimer. This reduced product monomer is then known to have a free-cysteine and this thiol 
(-SH2) can be used as a bifunctional linker to solid supports such as the glass surface of a 
coverslip or tissue culture plastic155. AKTA start was used for purification and this 
validates purity by verifying size of desired proteins and their unique purity through 
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collection of desired fractions (reference Appendix Figure A2 to AKTA profile). The yield 
of purified protein was estimated to be 10mg from a 1L culture. 
3.3.3 Quality Control Check 
The recombinant proteins have been optimized in both design and in use. Quality 
analysis was completed to verify purity and activity via SDS-PAGE, gel filtration, ELISA, 
Western Blot, and Crystal Violet Adhesion Assay studies. 
A phage based antibody probe called “H5” was isolated to selectively identify 
FnIII9-4G-10 over FnIII9*10. This antibody was then used to verify activity and purity of 
the recombinant protein fragments. Previously purified Fn fragments had shown a 
selectivity of H5 binding to the FnIII9-4G-10 fragment was approximately an order of 
magnitude greater compared to FnIII9*10. 
The results of this ELISA or protein coated well plates and detection with 
previously isolated antibody fragment scFv, “H5”, as well as a commercially available 
antibody HFN7.1, an antibody targeting FnIII9-10, binding to full-length Fn and Fn 
fragments can be seen in Figure 13.   
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Figure 13.  ELISA of H5 or HFN7.1 on various Fn substrates. H5 is the scFv phage-
based antibody fragment found to target FnIII9-4G-10 over FnIII9*10. HFN7.1 is a 
commercially available antibody used to target FnIII9-10 region. H5 bound FnIII9-
4G-10 to a significantly greater degree than FnIII9*10 at all concentrations (p < 
0.0001), whereas HFN7.1 only bound FnIII9-4G-10 to a significantly greater degree 
than FnIII9*10 at 1 M (p < 0.05) and was not significant at higher concentrations 
(Two-way ANOVA with Tukey’s post-test, N = 3) 
Antibody scFv H5 bound FnIII9-4G-10 to a significantly greater degree than 
FnIII9*10 at all concentrations (p < 0.0001), whereas HFN7.1 only bound FnIII9-4G-10 to 
a significantly greater degree than FnIII9*10 at 1 M (p < 0.05) and was not significant at 
higher concentrations (Two-way ANOVA with Tukey’s post-test, N = 3). The Fn 
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fragments were also visualized on nitrocellulose dot blots of H5 or HFN7.1 binding to full-
length Fn and engineered FnIII9-10 fragments (Figure 14).  
Figure 14. Nitrocellulose dot blots of H5 or HFN7.1 binding to full-length Fn and Fn 
fragments. 
In Figure 15 denaturing Western blots of H5 or HFN7.1 binding to full-length Fn 
and Fn fragments. The increased affinity of H5 to FnIII9-4G-10 versus FnIII9*10 is 
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observed in ELISA, but not in dot blot or traditional denaturing Western blots, suggesting 
that the epitope bound by H5 is likely not solely just a linear peptide sequence but instead 
a more complex 3D structure. 
Figure 15. Denaturing Western blots of H5 (E) or HFN7.1 (F) binding to full-length 
Fn and Fn fragments. 
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 Finally, experiments to observe cell activity are measured using an attachment 
assay and CHO cells that are designed to express specific integrins. CHO.K1 cells are 
designed for α5β1 expression and CHO.B2 cells are designed for αvβ3 expression. Using 
these cells and an attachment assay it is determined that CHO.K1 cells preferentially bind 
FNIII9*10 and CHO.B2 cells do not preferentially bind either fragment or full-length Fn 
which aids in the conclusions that FnIII9*10 will favor engagement with α5β1 integrins 
and FnIII9-4G-10 will favor engagement with αvβ3 integrins. Seen in Figure 16 I observe 
this trend to be true.  
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Figure 16. Crystal Violet analysis of cell attachment for CHO.K1 and CHO.B2 cells 
on various coating substrates. CHO.K1 cells express α5β1 integrins so their 
preference for FnIII9*10 verifies the hypothesized integrin “switch” behavior. 
CHO.B2 cells express αvβ3 and since it is hypothesized that both FnIII9*10 and 
FnIII9-4G-10 can bind to this integrin the similarity in cell binding is appropriate.  
3.4 Discussion 
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Since these engineered recombinant FnIII9-10 fragments were previously designed 
but the protein production process was inefficient, it was determined that the system should 
be re-engineered in order to optimize protein expression and simplify the purification 
process. The vector construct design is justified for incorporation of key design elements 
including the controllable induction via a lac operon, thrombin cleavage site, tdTomato 
fluorescent protein, and 10x His tag. The method was optimized and well characterized 
and the route to purification was easily traced via the fluorescent protein. A system to 
observe the protein during expression and purification was put in place. Quality assurance 
methods were developed to determine activity levels of the proteins and to make sure that 
based on these assays the proteins appear to have the correct conformations. Analysis of 
the quality of these proteins is important for every batch as mutations can occur easily 
which influence cell response. Recombinant FnIII9-10 fragments effects on normal human 
lung cells are further explored in subsequent chapters so the quality of the peptides that 
will coat the surfaces is important in order to observe key differences in cell response.  
The optimized expression design seemed effective. The design features provide 
valuable control of expression reducing the mutations that previously caused DNA 
mutations that dysregulated the system. Using many sequential His-tags increased the 
affinity of the desired protein to bind to the nickel column during purification. The 
tdTomato was valuable to track expression and purification of the protein from the cell 
lysate. Additionally the thrombin cleavage site allowed for successful clean cleavage 
between the FnIII9-10 fragment and the tdTomato + His tag. These features were 
successfully implemented and were tracked via visual observation and SDS-PAGE 
analysis. The plasmid backbone pBR322 had these additional engineered features that 
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allowed for successful regulation. To maintain low rate of DNA mutation it is also 
important to monitor freeze-thaw cycles of stocks and maintaining early generations of the 
clone. Frozen stocks of early generations can be made in mass quantity and aliquoted to 
small volumes to prevent excessive freeze-thaw. 
The use of these FnIII9-10 fragments can be of particular interest since the presence 
of force or mutational distanced type III repeats could result in preferential engagement of 
certain integrins over others. It has been seen that ECM protein conformations have been 
shown to affect integrin binding to the same protein. Different integrin binding could 
potentially lead to differential downstream cellular responses and ultimately could 
influence cell differentiation and phenotype characteristics.  
These fragments are essential for the continuation of the work in Markowski et al.  and 
Cao et al. and so the maintenance of these fragments for the remaining work discussed in 
this dissertation and for future projects is imperative29,43. It is known that small forces can 
regulate the distance between the RGD and synergy site. Alternatively these force mediated 
conditions can be mimicked by increasing linker chain length through point mutations 
between the two repeats which ultimately reduces α5β1 integrin binding (our Fn fragments, 
FnIII9-10)78. Previous work suggests that α5β1 integrin binding can be mediated 
mechanically by force stretching into this intermediate lengthened state or beyond. The 
influence of these alterations can have significant influence on cell fate. Further exploration 
into the effects of the engineered integrin mediated-Fn IBD on cell fate will be discussed 
in subsequent sections of this dissertation. 
 71 
CHAPTER 4. PROBING CELL BEHAVIOR IN RESPONSE TO 
RECOMBINANT FNIII9-10 FRAGMENTS 
4.1 Introduction  
4.1.1 CCL-210 
 CCD19Lu (ATCC® CCL210™) are primary human normal lung fibroblasts. 
These cells are used in this work to probe events that may trigger these normal cells to 
being to manifest characteristics closer to myofibroblasts or at least mimic phenotypes that 
may be present in fibrosis. CCL210s are known to express α5β1 and αvβ3 integrins, and 
we hypothesize they will respond to biochemical and physical cues through differential 
integrin engagement. Others such as Wang et al. have used CCD19Lu (ATCC® CCL-
210™) to explore potential therapeutic options for lung fibrosis. Understanding the 
responses of these cells to their environment can direct our understanding of the diseased 
tissue in vivo and how these lung fibroblasts can help us to understand the relationship 
between cell-matrix interactions and their role as drivers in fibrotic disease. 
4.1.2 Focal Adhesions 
 A focal adhesion refers to the contact between a cell and the extracellular matrix 
through interactions between transmembrane proteins referred to as integrins and 
intracellular ligands. The intercellular multiprotein focal adhesion complexes that are 
connected the actin cytoskeleton upon these contacts modulate mechanical force sensing 
and transmit regulatory signals that are transmitted between the environment and the cell 
and can regulate cell motility and other phenotypes contributing to functional diversity 
 72 
within cell populations and tissues. These physical connections to the ECM can provide 
sensory responses, which inform the cell about the architecture and composition of the 
ECM and ultimately can affect cellular behavior. The ECM provides both biochemical cues 
(through protein orientation) and mechanical stimuli (through varying matrix stiffness). 
These components among other such as present growth factors and cytokines and 
triggering event like inflammation or injury can provide information to the cell about how 
it should behave. Lung fibroblasts can respond to their environment based on changes in 
matrix composition, rigidity, and matrix protein conformation. The cell’s stability is in flux 
as the cell migrates and FAs are associating and dissociating as the leading edge of the cell 
builds new contacts and the trailing edge contacts are broken28. In wound healing focal 
adhesion maturation transduces cell signals from the environment to trigger the healing 
events and cell signals associated with this phenomena. Fibroblasts respond to wounds in 
three discrete phenotypic ways: recruitment, differentiation, and resolution. After injury 
activation and recruitment of fibroblasts to the site of injury is initiated156. Fibroblastic 
proliferation is triggered based on the recruited fibroblasts engaged with inflammatory 
cytokines157. Evidence also indicates that matrix stiffness stimulates fibroblast proliferation 
as well5. After the provisional matrix tissue is deposited the local fibroblasts undergo 
transition to differentiated myofibroblasts or “activated” fibroblasts. The cells now known 
as myofibroblasts will continue to synthesize and assemble matrix proteins and with apply 
contractile forces triggering the expression of α-SMA into contractile filaments furthering 
their force influence158. 
4.1.3 Integrins αvβ3 and α5β1 
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Integrins are heterodimeric transmembrane receptors that link the cell’s 
cytoskeleton and the ECM142. Published works have indicated that integrin affinity can 
result from conformational changes in the ECM159,160.Fn matrix assembly is matrix 
assembly into Fn fibrils evidenced by the fact that cells which lack αv and α5 integrin 
subunits fail to assemble fibrils even though their matrix protein secretion is unaffected144. 
Although it is known that many integrins can bind to Fn the integrin α5β1 is the major 
regulator of this relationship and the integrin that cells primarily use to engage and 
assemble Fn molecules into the ECM145,146. Well-studied integrins are αvβ3 and α5β1 
integrins  are both known to engage RGD within FnIII10; however, it has been shown that 
α5β1 is a synergy dependent integrin meaning that it is responsive to Fn’s IBD when RGD 
(FnIII10) and the synergy site, PHSRN, (FnIII9) are coordinated in a spatial conformation 
that allows access to both sites22,92,161. Recent evidence indicates that the fibroblast 
integrins αvβ3 and α5β1 can work together to improve rigidity sensing on an Fn-based 
substrate148. This improved mechanosensing has implications in cell migration and 
invasion present in known fibrotic pathologies. It is hypothesized that the spatial 
relationship between RGD and PHSRN may result in differential integrin engagement and 
mediation of different signaling events associated with specific integrin engagement. This 
integrin “switch” has been characterized with endothelial cells and HFFs but it is of interest 
to look at lung fibroblasts due to their role in pulmonary fibrosis. If confirmed, the integrin 
“switch” could be a potential target for therapeutic options162.  
4.1.4 Downstream signaling 
The physical attachment site between cells and the ECM are integrin-based 
adhesions. Adhesions of associated molecules are clustered at the site of integrin and 
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cytoskeletal forces. In this thesis, we refer to these molecular clusters as focal adhesions 
(FAs). On the cytoplasmic tails of integrins the associated proteins serve as scaffolds which 
include cytoskeletal binding and other adaptor proteins (kinases and phosphatases)120. 
Propagation of biochemical signals are triggered based on the macromolecular complexes 
associated with these FAs. It is known that FAs are mechano-sensitive and can grow and 
change composition in response to mechanical force118,119. Based on these conclusions it is 
known that specific proteins are recruited to FAs and trigger specific downstream 
responses in a force-dependent manner120,163164. Scaffolding molecules like paxillin, a 
nascent complex, will form at the leading edge of FAs. Activation of downstream signaling 
molecules such as focal adhesion kinase (FAK) and Src in response to increased 
mechanical tension can occur as ECM ligation occurs and FAs assemble and turnover124. 
Interestingly, when exogenous force is applied to integrins similar signaling pathways are 
stimulated by internally generated forces. Work by Choquet et al. demonstrated that 
adhesion reinforcement and cytoskeletal linkage is localized and strengthened  in response 
to cells sensing the restraining force that is applied by Fn-coated beads165. The 
rearrangement of the cytoskeleton results in stiffening of the cell at the cell-ECM 
interface125. The receptor-ligand reaction landscape and potential for cryptic binding site 
exposure may be altered by single molecule force and could modulate the output and 
dynamics f downstream signaling pathways. This is demonstrated through the cytoskeleton 
associated protein interin126,127. The complexity of FA architecture, composition, and 
interactions make resolving mechano-signaling a challenge. 
4.1.5 MRTF and actin relationship 
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Through examination of MRTF nuclear localization gene expression myofibroblast 
differentiation and potential for wound healing activity can be monitored. Since nuclear 
localization of MRTF indicates a myofibroblast phenotype observation of this effect on 
variable substrates may indicate how myofibroblastic the cells appear to be. It is known 
that enhanced polymerization of F-actin precedes nuclear localization of the cytoplasmic 
G-actin bound transcription factor MRTF. In the nucleus MRTF complexes with serum 
response factor and continues to drive α-SMA expression indicative of myofibroblast 
differentiation166,167. In response to stress, MRTFs are essential regulators of the smooth 
muscle contractile phenotype so monitoring their behavior can provide important 
indications of the relationship between MRTF and cytoskeletal dynamics. The relationship 
known that cytoskeletal actin polymerization signals the MRTF cofactor and induces 
nuclear transcription of SRF which then modulates the expression of genes which can 
further have regulatory and structural impacts that further link the cytoskeleton dynamics 
with genome activity (Actin-MRTF-SRF)168. Fibrotic disease could be treated through 
inhibition of the myofibroblast differentiation and wound healing regulatory pathways 
since their dysregulated activation is what leads to the disorder.  
4.1.6 Phenotypes of myofibroblasts 
 Myofibroblasts are activated fibroblast cells physiologically found in wound and 
pathologically associated as the effector cell of fibrosis. These cells once activated can be 
distinguished by known phenotypes: differential integrin engagement, phosphorylation of 
FA associated proteins (FAK and Src), paxillin formation, MRTF nuclear localization, 
increased adhesion, increased cell contractility, increased cell proliferation and 
metabolism. Other indicators of activated fibroblasts include increased matrix synthesis 
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and generally increased anabolism, and resistance to apoptosis but these have not been 
explored in this work. Metabolic reprogramming is associated with myofibroblast 
differentiation and increased proliferation is a known phenotype of myofibroblasts as well. 
It is known that α-SMA expression should increase as cells differentiate towards a 
myofibroblast phenotype.  
 It is believed that as cell phenotype changes due to the sensitivity of lung fibroblasts 
to Fn IBD a feedback loop is created due to increased cell contractility and additional 
matrix deposition which then further destabilizes the proteins in the matrix. The 
recombinant Fn fragment variants allow a controlled system which can probe the integrin 
relationship with outputs on cell phenotype. Once the phenotypic effects on lung fibroblasts 
are characterized potential therapeutics can be tested to observe their influence on cell 
behavior (furthering myofibroblast differentiation or re-initiating proper wound healing 
and resolution). 
4.2 Materials and Methods 
4.2.1 Cell Culture 
CCL-210 cells, normal human lung fibroblasts, were obtained from ATCC and 
maintained in DMEM media supplemented with 10% FBS and 1% Penicillin Streptomycin 
(PenStrep). For experiments analyzing the role of FnIII9-10 fragments on directing cell 
behavior, cells were plated on 0.1-8µM Fn-fragment coated glass coverslips, TC plastic, 
or Matrigen HTS hydrogel plates for 15 minutes - 48 hours depending on the experiment. 
Surfaces were then blocked with 1% hd-BSA and were sometimes cultured for experiments 
in serum-free, low serum (0.2-2% FBS), or full serum (10% FBS) DMEM. 
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4.2.2 Immunofluorescent Staining (αv and α5 Integrin) 
For experiments analyzing the role of FnIII9-10 fragments on integrin engagement, 
glass coverslip surfaces were coated with 4µM overnight at 4°C. Surfaces were then 
blocked with 1% hd-BSA and were then cultured (6,000 cells/cm2 at 37°C) for the 
experiment in full serum (10% FBS) DMEM for 15 - 60 minutes. Samples were fixed with 
acetone:methanol 1:1 mixture at -20°C for 5 minutes. Cells were permeabilized with 0.1% 
Triton X-100 and then blocked with 5% NGS for 1 hour. Cells were then incubated with 
1:500 of AB1928 (Millipore) anti-α5 rabbit antibody and 1:200 AB16821 anti-αv mouse 
antibody. After primary stain overnight at 4°C the secondary stain of anti-mouse 546 
(Invitrogen) and anti-rabbit 488 (Invitrogen) as well as Phalloidin (Alexa Fluor 488 
Phalloidin, Invitrogen, 1:2000) was used for immunofluorescent imaging. Cell were 
incubated for 1 hour in secondary antibodies then 1 minute Hoescht (Thermo Fischer 
Scientific) nuclear stain and mounting to slides with ProLong Gold Antifade Mountant 
(Thermo Fischer Scientific). Ratiometric images were generated using an in-house 
MATLAB algorithm. Images were thresholded using Otsu’s method, and masked based on 
where both α5 and αv signals passed the threshold. Fluorescence intensity of α5 staining 
was then divided by staining intensity of αv29.  
4.2.3 Immunofluorescent Staining (Paxillin) 
Plate was coated with protein (Fn, FnIII9*10, FnIII9-4G-10) overnight at 4°C and 
blocked for 1 hour with 1% hdBSA. Cells were seeded at a density of about 6,000 cell/cm2 
in 10% FBS (full-serum) DMEM conditions. Cells were given 1-25 hours to attach and 
spread in response to the biochemical presentation of the proteins. Controls were all treated 
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appropriately before fixation (1% BSA and no primary). Cells are fixed with 4% PFA for 
10 mins for each time point and permeabilized in 0.2% Triton X-100 for 5 minutes. 
Coverslips are washed 3x with 1xPBS and blocked with 5% NGS for 1 hour at room 
temperature. Cells are then stained with primary antibody (Anti-Paxillin Rabbit, clone 
Y113, EMD Millipore, 1:200) overnight at 4°C. Cells are then washed three times with 
1xPBS and stained in secondary antibody (Alexa Fluor 546 goat anti-Mouse, Invitrogen, 
1:2000 and Alexa Fluor 488 Phalloidin, Invitrogen, 1:2000) at room temp for 1 hour. Cells 
were incubated with 1:1000 Hoechst (thermos Fischer Scientific) nucelar stain for 1 min, 
wash 3 x with PBS and once with DIH2O. Samples were mounted using ProLong Gold 
Antifade Mountant (Thermo Fischer Scientific) and later sealed using clear nail polish. 
Images were acquired with PerkinElmer UltraVIEW VoX using Spinning Disk detector 
Hamamatsu FLASH 4 sCMOS version 2 and a 60x Oil objective on a Nikon Ti-E with 
Perfect Focus 3. 
4.2.4 Magnetic Bead Pull-down Assay 
Approximately 3x106 CCL-210 cells are plated on several 100 mm TC plastic petri 
dishes. Magnetic Dynabeads, (Dynabeads M-280 Tosylactivated, Invitrogen), are coated 
with Fn, FnIII9*10, and FnIII9-4G-10 (50μg). After preparation of the beads the bead 
suspension was added to the cell plates and they are allowed to incubate for ~40 minutes. 
Magnet is applied to provide 10-16pN of magnetic force to activate the cell focal adhesions 
which are conjugated to the Fn/Fn fragment coated magnetic beads for variable time (0-30 
minutes). Cells are collected and lysed with 2x laemmli buffer and collections from the 
beads (the force-induced focal adhesion proteins) were analyzed to verify concentration 
using a Pierce 660nm Protein Assay Reagent with 50mM Ionic Detergent Compatible 
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Reagent (IDCR)  and then SDS-PAGE and Western blots were performed . After transfer 
to nitrocellulose membrane and blocking with 5% milk primary antibodies (pY397-FAK 
(1:1,000, rabbit, 44-624G; Invitrogen), c-Src (1:1,000, rabbit, 32G6; Cell Signaling 
Technology), FAK (1:1000, rabbit, ab40794; Abcam), and pY416-SFK (1:1,000, rabbit, 
2101; or 1:1,000, rabbit, D49G4; Cell Signaling Technology) were incubated overnight at 
4°C. Next, secondary antibody (Goat anti-Rabbit IgG secondary antibody, HPR 
conjugated, 31460, ThermoFisher) was incubated for 1 hour. Stained proteins were 
observed using a Bio-Rad ChemiDoc imaging system based on size (Src/p-Src 
MW~56kDa and FAK/p-FAK MW~110kDa). 
4.2.5 Size and Shape Analysis of Cell Body 
Plate was coated with protein (Fn, FnIII9*10, FnIII9-4G-10) overnight at 4°C and 
blocked for 1 hour with 1% hdBSA. Cells were seeded at a density of about 5,000 cell/cm2 
in 10% FBS (full-serum) DMEM conditions. Cells were given 1-25 hours to attach and 
spread in response to the biochemical presentation of the proteins. Controls were all treated 
appropriately before fixation (1% BSA and no primary). Cells are fixed with 4% PFA for 
10 mins for each time point and permeabilized in 0.2% Triton X-100 for 5 minutes. 
Coverslips are washed 3x with 1xPBS and blocked with 5% NGS for 1 hour at room 
temperature. Cells are then washed three times with 1xPBS and stained in Alexa Fluor 488 
phalloidin, Invitrogen, 1:2000 at room temp for 1 hour. Cells were incubated with 1:1000 
Hoechst (Thermo Fischer Scientific) nuclear stain for 1 min, wash 3 x with PBS and once 
with DIH2O. Samples were mounted using ProLong Gold Antifade Mountant (Thermo 
Fischer Scientific) and later sealed using nail polish. Images were acquired with 
PerkinElmer UltraVIEW VoX using Spinning Disk detector Hamamatsu FLASH 4 
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sCMOS version 2 and a 60x Oil objective on a Nikon Ti-E with Perfect Focus 3. Cell area 
was measured with an intensity-based auto-detection algorithm within the PerkinElmer 
Volocity software that allows for specific identification of cell borders and pixel number.  
4.2.6 Crystal Violet Attachment Assay 
Cell attachment assays were performed as previously described153. Briefly, surfaces 
were coated with 2µM Fn fragments (FnIII9*10 and FnIII9-4G-10 have similar coating 
efficiencies) or 10µg/mL full length WT Fn and blocked with 1% hd-BSA92,154. CCL-210’s 
were analyzed for their adhesion on carious surfaces. Cells were seeded at 15,000-30,000 
cells/well and were allowed to attach for approximately 20 minutes at 37°C in 10%-serum 
DMEM then washed to remove unbound cells, fixed with 5% glutaraldehyde, and stained. 
A 0.1% crystal violet solution was used to stain the cells. After drying the stain was 
solubilized with 10% acetic acid and absorbance was quantified on the BioTek H4 
Microplate Reader at 570nm. Linear regression was performed on the standard curve to 
determine reliability of the assay. Attachment values were normalized to cell attachment 
levels hd-BSA (0% attachment). Data from the triplicate experiment was normalized to the 
cells remaining in the highest cell density wells from the standard curve and presented as 
average +/- standard error. Normalized remaining cell percentage is presented on the y-
axis.  
4.2.7 CyQuant Assay 
CCL-210’s are serum-starved for 2 days in serum-free (no FBS) DMEM.  Proteins 
(Fn, FnIII9*10, FnIII9-4G-10, were used to coat a 96-well plate at varying concentrations 
overnight at 4°C. The wells were then washed 3x with 1xPBS, blocked with 1% hdBSA 
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for 1 hour at room temperature, washed again 3x with 1xPBS. Cells were then trypsinized 
and plated into 96-well plate at 10,000-20,000 cells/well (100,000-200,000 cell/mL) in 
10% Fn-depleted DMEM. Growth was monitored at variable time points (16-24 hours). 
Detection Reagent 2x is prepared with PBS, CyQuant Direct nucleic acid stain and 
CyQuant Direct background suppressor I (Thermo Fischer). Equal volume of 2x Detection 
Reagent was added to wells and incubated at 37°C for 1 hour. Flourescence is read on 
BioTek micro plate reader bottom up at excitation/emission 508nm and 527nm 
respectively. 
4.2.8 MTT Assay 
 Cells were serum-starved for 2 days in DMEM without phenol red. Proteins (Fn, 
FnIII9*10, FnIII9-4G-10, were used to coat a 96-well plate at varying concentrations 
overnight at 4°C. The wells were then washed 3x with 1xPBS, blocked with 1% hdBSA 
for 1 hour at room temperature, washed again 3x with 1xPBS. Cells were then trypsinized 
and plated into 96-well plate at 20,000 cells/well (200,000 cell/mL). Media conditions were 
described as low serum (0.2% FBS) media and full serum (10% FBS).  Most wells are 
plated with cells in low serum except for a control. All samples are run in triplicate. Control 
wells for TGF-β (Recombinant Human TGF-β1, Fisher Scientific, 5 ng/mL, addition at 
initial cell plating) and LatB (Latruculin B, Sigma-Aldrich, 2 µM, 30 minutes prior to 
assay) were prepared as well. Cells were incubated for 16-48 hours at 37°C. After 
incubation the media was removed and fresh media was added. Next, 10 µl of 12 mM (5 
mg/mL) of the MTT dye (MTT Cell Proliferation Assay, Thermo Fischer Scientific) is 
added to the wells. The MTT dye is photosensitive so it is protected from the light. Plate is 
then incubated for 3 hours at 37°C and purple soluble formazan is visible with tabletop 
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microscope 10x (See Appendix). Next, 85µL of medium was removed from each well and 
50µL of DMSO was added to dissolve the formazan and mixed thoroughly. The plate was 
then incubated for 10 minutes at 37°C, samples are mixed again, and cells are read on 
BioTek micro plate reader at excitation/emission 540nm and 570nm respectively.  
4.2.9 Immunofluorescent Staining (MRTF) 
Plate was coated with protein (Fn, FnIII9*10, FnIII9-4G-10) overnight at 4°C and 
blocked for 1 hour with 1% hdBSA. Cells were seeded at a density of about 5,000 cell/cm2 
in 10% FBS (full-serum) DMEM conditions. Cells were given 1.5-4 hours to attach and 
spread in response to the biochemical presentation of the proteins. Controls (LatB 
(Latrunculin B, Sigma-Aldrich, 2 µM, 30 minutes prior to assay) and Cytochalasin D 
(Sigma-Aldrich, 40 minutes prior to fixation)) were all treated appropriately before fixation 
(1% BSA and no primary). Cells are fixed with 4% PFA for 10 mins for each time point 
and permeabilized in 0.2% Triton X-100 for 5 minutes. Coverslips are washed 3x with 
1xPBS and blocked with 5% NGS for 1 hour at room temperature. Cells are then stained 
with primary antibody (Anti-MKL1 antibody (anti-MRTF-A), Rabbit, 1:500, Sigma 
Aldrich) overnight at 4°C. Cells are then washed three times with 1xPBS and stained in 
secondary antibody (Alexa Fluor 546 goat anti-Rabbit, Invitrogen, 1:2000 and Alexa Fluor 
488 phalloidin, Invitrogen, 1:2000) at room temp for 1 hour. Cells were incubated with 
1:1000 Hoechst (Thermo Fischer Scientific) nuclear stain for 1 min, wash 3 x with PBS 
and once with DIH2O. Samples were mounted using ProLong Gold Antifade Mountant 
(Thermo Fischer Scientific) and later sealed using nail polish. Images were acquired with 
PerkinElmer UltraVIEW VoX using Spinning Disk detector Hamamatsu FLASH 4 
sCMOS version 2 and a 60x Oil objective on a Nikon Ti-E with Perfect Focus 3. Single 
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cells or multicellular aggregates are segmented based on actin and nuclear signaling, and 
MRTF signal in each compartment is background corrected (using intensities from the no 
primary control).  Ratios of background corrected MRTF signal from the whole cells and 
from the nuclear compartment are used to estimate the nuclear fraction of MRTF. 
4.3 Results 
4.3.1 Integrin staining (α5 and αv) 
This experiment seeks to characterize the integrin expression of CCL-210, normal 
human lung fibroblasts, on different FnIII9-10 fragments at varying time points (30 and 45 
minutes). It is hypothesized that cells will begin to lay down their own Fn matrix around 4 
hours after attachment so there is validity in observing the initial attachments (~30-45 
minutes) and the integrins associated with the focal adhesions associated at that time 
(applied force 1-30 minutes). Previous work completed in Cao et al. on integrin staining 
of αv and α5 provides insight into the specific integrins that are engaged on these same 
engineered Fn fragments utlized in this work29. Immunofluorescence staining of integrins 
on human foreskin fibroblasts cultured on these Fn fragments confirms that this molecular 
modification results in a switch in the integrin binding profile from 51 and v3 to 
predominantly v3 at the cellular level (Figure 17), supporting earlier reports of 
FnIII9*10 fragment’s ability to engage α5β1 integrins preferentially92.    
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Figure 17. HFFs immunostained for integrins α5 and αv. Fibroblasts cultured on 
FnIII9*10 and FnIII9-4G-10 fragments and immunostained for integrins α5 and αv 
demonstrate the fragments’ capability of skewing cellular binding toward specific 
integrins.  Scale bar is 20 µm. 
Comparison of this effect on the normal human lung fibroblasts was explored to 
determine if the same trend was apparent, but here the trends are similar but not as stark 
(Figure 18). The ratio of α5 to αv integrin engagement is less significant; however, the 
trend of preferred engagement of α5β1 on FnIII9*10 substrate and αvβ3 on FNIII9-4G-10 




Figure 18. Ratiometric analysis of α5:αv using in-house MATLAB script. Slight 
differences are apparent visually for interpretation of greater α5 engagement on 
FnIII9*10 and full-length Fn. 
By observing the quantitative differences in Figure 19 it can be examined if there 
are significant differences between the α5:αV ratio of CCL-210s on substrate FnIII9-4G-
10 and FnIII9*10 (*p<0.05 at both 30 and 45 minutes) as well as between FnIII9-4G-10 
and full-length Fn (*p<0.05 at 30 minutes, ***p<0.0005 at 45 minutes). However, the 
mean values of each condition appear to sit within the deviation calculated at each value. 
This can make our determination of the true significance of these differences unclear  
FnIII9*10 Fn FnIII9-4G-10 
Ratiometric analysis of integrin α5:αv at 30 minutes  
FnIII9*10 Fn FnIII9-4G-10 
Ratiometric analysis of integrin α5:αv at 45 minutes  
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Figure 19. Quantitation of integrin staining intensity on Fn fragments and full length 
Fn. Human lung fibroblasts were seeded onto fragments (FnIII9*10 or FnIII9-4G-10) 
or full-length Fn in serum free media, fixed at 30 or 45 minutes, and stained for α5 
and αv as described in Methods and materials. Ratiometric images of each cell were 
generated by thresholding individual channels and dividing α5 by αv. Median α5:αv 
values were calculated for each image and compared using one-way ANOVA with 
Tukey’s post-test, N = 10 cells for each condition. *p < 0.05 and ****p<0.0005. 
Overall, these results indicate that there may be an increased presence of α5 to αv 
integrin within CCL-210’s focal adhesions on FnIII9*10 in comparison to the FnIII9-4G-
10 fragment; however the effect does seem to be dampened when compared to other cell 
results such as HFFs (Figure 17). This could result from CCL-210’s having a different 
integrin profile which may contain more αv containing integrins muddling the signal ratio. 
Since previous works suggested that the spatio-temporal relationship of RGD and PHSRN 
sites serve as an on/off switch for α5β1 binding to Fn such that destabilization between 
these sites may turn off the “switch” for α5 integrin binding we can compare these findings 
to our work. Although this theory seemed supported by our results, it appears that the 
“switch” behavior is less dramatic with CCL-210 human lung fibroblasts. This could be 
indicated in their expression of other αv integrins besides only αvβ3 (such as αvβ5). A 
relative dominance of these integrin switch behaviors may be dampened by the fact that 
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both Fn fragments will engage αvβ3 integrins. It appears that the mutation between the 
RGD and synergy sites is sufficient to drive fibroblasts to predominantly attach through αv 
and not α5. 
4.3.2 Paxillin-containing Focal Adhesions 
Paxillin was interrogated to characterize the size, position and number of focal 
adhesions present between CCL-210’s and the recombinant Fn fragment matrix using 
immunofluorescence at variable time points (1, 3, 7, 25 hours). In this experiment we can 
compare FnIII9-4G-10 and FnIII9*10 by observing the morphology, length, and location 
of paxillin-containing focal adhesions and their formation over time via staining of the 
paxillin molecule. The results apparent in Figures 20-23 indicate that the focal adhesions 
seen on full-length Fn are both distal, extended, distinct, and have a clear polarized 
morphology as early as 1 hour after plating. The cells on Fn appear to be in a migratory 
lamellipodia as the focal adhesions are attaching to the leading edge and absent from the 
tailing edge. Whereas in Fn the adhesions are clear at early time points (as early as 1 hour) 
there are differences in the fragment-associated focal adhesions in a temporal-dependent 
manner. On Fn9*10 there are significantly less prominent focal adhesions formed at earlier 
time points (1 and 3 hours); however, after 7 hours when it is believed that the cells have 
begun to lay down their own matrix consisting of self-assembled Fn there are indications 
of more distinct distal focal adhesions. On FnIII9-4G-10 we see prominent focal adhesion 
indicated in paxillin staining on early time points including 1 and 3 hours and we see this 
trend continue as it aligns with the results seen on FnIII9*10 at 7 and 25 hours as cells have 
begun to lay down their own Fn matrix and the focal adhesions formed at these later time 
points probably indicate the adhesion to the newly assemble Fn. In both FnIII9-4G-10 and 
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FnIII9*10 we do not see the same migratory pattern indicated by paxillin staining a leading 
and lagging end as was seen on full-length Fn.  
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Figure 20. Paxillin immunostaining of FAs at 1 hour on FnIII9*10, FnIII9-4G-10, and 
full-length Fn. CCL-210 cells cultured on FnIII9*10 and FnIII9-4G-10 fragments and 
immunostained for DAPI, Paxillin, and Actin demonstrate the fragments’ capability 
of skewing focal adhesion formation. Scale bar is 20 µm. 
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Figure 21. Paxillin immunostaining of FAs at 3 hours on FnIII9*10, FnIII9-4G-10, 
and full-length Fn. CCL-210 cells cultured on FnIII9*10 and FnIII9-4G-10 fragments 
and immunostained for DAPI, Paxillin, and Actin demonstrate the fragments’ 
capability of skewing focal adhesion formation. Scale bar is 20 µm. 
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Figure 22. Paxillin immunostaining of FAs at 7 hours on FnIII9*10, FnIII9-4G-10, 
and full-length Fn. CCL-210 cells cultured on FnIII9*10 and FnIII9-4G-10 fragments 
and immunostained for DAPI, Paxillin, and Actin demonstrate the fragments’ 
capability of skewing focal adhesion formation. Scale bar is 20 µm. 
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Figure 23. Paxillin immunostaining of FAs at 25 hours on FnIII9*10, FnIII9-4G-10, 
and full-length Fn. CCL-210 cells cultured on FnIII9*10 and FnIII9-4G-10 fragments 
and immunostained for DAPI, Paxillin, and Actin demonstrate the fragments’ 
capability of skewing focal adhesion formation. Scale bar is 20 µm. 
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4.3.3 Force-mediated Focal Adhesion Complex Associated Proteins 
To understand whether FnIII9-4G-10 and FnIII9*10 affect mechano-transduction, 
a magnetic bead pull-down assay was used. Pre-coated magnetic beads with FnIII9-4G-10 
or FnIII9*10 fragment (or full-length Fn) were incubated with CCL-210 cells then 
magnetic force (10-16pN) was applied to active cell focal adhesion conjugated with 
magnetic beads through the active magnetic force pulling out the magnetic beads. Our 
results showed that force induced phosphorylation of FAK significantly increases in 
FnIII9-4G-10 but not in FnIII9*10 group. Interestingly, force activated phosphorylated Src 
was not detected to change in any significant amount with FnIII9*10 nor the FnIII9-4G-10 
group (Figure 24, Figure 25). Based on previous work completed in Fiore et al. the pFAK 
expression levels at 5 minutes seem consistent for FnIII9-4G-10; however, the lack of pSrc 
increase seems to counter previous results found when cells engaged with full-length Fn. 
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Figure 24. Magnetic bead analysis of phosphorylation of Src with 5 mins force 
application. CCL-210s are cultures and given time to adhere with magnetic bead 
coated with Fn variants. Force is not applied (N) or applied (P) for 5 minutes and 
increase in p-Src on FnIII9*10 were observed. 
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Figure 25. Magnetic bead analysis of phosphorylation of FAK with 5 mins force 
application. CCL-210s are cultured and given time to adhere with magnetic bead 
coated with Fn variants. Force is not applied (N) or applied (P) for 5 minutes and 
increase in p-FAK on FnIII9-4G-10 were observed. 
To confirm how magnetic force applied over time affected the phosphorylation of 
FAK and Src based on presentation with FnIII9-4G-10 or FnIII9*10, we measured p-FAK 
and p-Src at 1, 5, 10 and 30 minutes. These results showed phosphorylation of FAK raised 
at 1 min and sustained for 30 mins when presented with FnIII9-4G-10. However, on FnIII9-
4G-10 we do not see influence on Src phosphorylation levels through 30 minutes of applied 
force. For the cells exposed to magnetic beads coated with FnIII9*10 the phosphorylation 
at Src appeared to happen earlier than the phosphorylation of FAK. Increasing levels of 
phosphorylation of Src was detected at 5 mins and came back to basal line at 10 mins. 
However, FAK phosphorylation increased at 10 to 30 mins after forced applied concluding 
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that the results on FnIII9*10 appear much less consistent and may not be reliable (Figure 
26 and Figure 27).  
 
Figure 26. Magnetic bead analysis of magnetic FnIII9*10 coated beads from 0-30 
minutes. CCL-210s are cultured and given time to associate with magnetic bead 
coated with FnIII9*10. Force is applied for 0-30 minutes and changes in 
phosphorylation of FAK and Src over this time are observed.  
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Figure 27. Magnetic bead analysis of magnetic FnIII9-4G-10 coated beads from 0-30 
minutes. CCL-210s are cultured and given time to associate with magnetic bead 
coated with FnIII9-4G-10. Force is applied for 0-30 minutes and changes in 
phosphorylation of FAK and Src over this time are observed. 
Band intensity of the western blots was analyzed to visually compare the influence 
of each fragments force-mediated focal adhesion complex associated proteins (FAK and 
Src). The values were normalized to the no-force control. Normalized quantitative values 
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above 1.5 indicate a reliable increase in phosphorylation, indicated on FnIII9-4G-10 coated 
beads over time of applied force (Figure 28). 
 
Figure 28. Quantitation of normalized intensities for magnetic bead analysis FnIII9-
4G-10 and FnIII9*10 for 0-30 minutes of applied force. Values are normalized to no-
force control for FAK and Src phosphorylation levels. Fold increase >1.5 indicated 
significant regulation of adaptor proteins. Consistent results seen with FnIII9-4G-10 
coated beads influence on FAK phosphorylation levels. 
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4.3.4 Size and Shape for Cell Contractility 
Cell contractility has been shown to scale with cellular spread area and polarity169. 
Therefore, observation of cell contractility was determined in this experiment through 
comparison of cell size (surface area and perimeter) and shape (polarity vs circularity). In 
this experiment both shorter (30, 45, 60, 90, 120, 240 mins) and longer (1, 3, 7, 25 hour) 
time points are analyzed (Figure 29-34). The data show different trends in the shorter and 
longer time points indicating that the CCL-210s may kinetically engage the different 
substrates differentially. In the earlier time points it appears that cells on all substrates (full-
length Fn, FnIII9*10, and FnIII9-4G-10) appear to be roughly similar in size; however, 
there is indication that FnIII9*10 seems to be initially (after ~ 1 hour) more polar with 
FnIII9-4G-10 become more polar around the 4 hour mark.  
Figure 29. Surface area analysis at time point range (30-240 mins). CCL-210 cells are 
cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine surface area of individual cells. Mean values of the surface area of actin is 
calculated for each image and compared using multiple t-test for each coating 




Figure 30. Cell perimeter analysis at time point range (30-240 mins). CCL-210 cells 
are cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine the perimeter of individual cells. Mean values of the perimeter of actin is 
calculated for each image and compared using multiple t-test for each coating 






Figure 31. Circularity analysis at time point range (30-240 mins). CCL-210 cells are 
cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine circularity of individual cells (circularity= 4π (area/perimeter2)). Mean 
values of the surface area of actin is calculated for each image and compared using 
multiple t-test for each coating substrate, N = 30 cells for each condition. **p < 0.05, 
***p<0.001, ****p<0.0001. 
The trend of FnIII9-4G-10 becoming even more polar over time is enhanced at the 






Figure 32. Surface area analysis at time point range (1-25 hours). CCL-210 cells are 
cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine surface area of individual cells. Mean values of the surface area of actin is 
calculated for each image and compared using multiple t-test for each coating 








Figure 33. Cell perimeter analysis at time point range (1-25 hours). CCL-210 cells are 
cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine the perimeter of individual cells. Mean values of the perimeter of actin is 
calculated for each image and compared using multiple t-test for each coating 





Figure 34. Circularity analysis at time point range (1-25 hours). CCL-210 cells are 
cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and 
immunostained for Hoescht nuclear stain and Actin. Volocity software is used to 
determine circularity of individual cells (circularity=4π(area/perimeter2)). Mean 
values of the surface area of actin is calculated for each image and compared using 
multiple t-test for each coating substrate, at least N = 15 cells for each condition. **p 
< 0.05, ****p<0.0001. 
4.3.5 Cell Adhesion Assay 
To characterize how human lung fibroblasts attach to different FnIII9-10 variants, 
CCL-210 human lung fibroblasts were analysed via a crystal violet attachment assay. The 
results of this assay demonstrate that although full-length Fn has the greatest ability for cell 
adhesion, likely due to the complex nature of the molecule and the related influences of 
other cell-binding components, the engineered Fn fragments appear to have differences in 
cell attachment as well. These results indicate that FnIII9*10 shows more cell adhesion 
than cells plated on FnIII9-4G-10. Seen in Figure 35 we observe this trend to be true. The 
results shown are presented as percent attachment compared to attachment on high density 
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cells on Fn. Overall, these results indicate that stabilization of the RGD and synergy sites 
in FnIII9*10 variant facilitate cell attachment over FnIII9-4G-10. 
Since adhesion is related to integrin engagement the ability of FnIII9*10 to bind 
both αvβ3 and α5β1 this is the suggested interpretation of the data. However, increased 
elevated, activated adhesion signaling is a key phenotypic indicator of fibrotic cells. 
Adhesion could be an indicator for cell persistence as well. 
 
Figure 35. Crystal Violet Attachment Assay of CCL-210s on full-length Fn and 
FnIII9-10 variants. CCL-210 cells are cultured on FnIII9*10 and FnIII9-4G-10 
fragments (and full-length Fn) and stained using crystal violet dye. Attachment is 
determined based on cell percentage remaining after washing (determined based on 
high density cells on Fn).  
4.3.6 CyQuant Proliferation Assay 
The CyQuant Direct Cell Proliferation Assay is a cell-permeable nucleic acid dye 
which allows detection of DNA content and membrane integrity. Many additional factors 
can influence metabolic activity (such as media conditions, confluence, and passage 
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number) therefore studying proliferation is an important observation, unique from 
metabolism. Myofibroblasts are thought to have a higher replication rate than quiescent 
fibroblasts therefore analyzing cell proliferation can indicate myofibroblast differentiation. 
The results presented in Figure 36 indicate that there are difference in proliferation rate 
between FnIII9*10 and FnIII9-4G-10. The difference on the substrates is significant at 
**p< 0.05 comparing both fragments at 8µM concentrations. This trend remains similar as 
the concentration decreases. Although full-length Fn and FnIII9-4G-10 do not appear to 
have stark differences in proliferation there is a significant increase in FnIII9*10 over Fn 
of **p< 0.05. 
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Figure 36. CyQuant analysis of cell proliferation at 24 hours on Fn and Fn variants. 
CCL-210 cells are cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-
length Fn) and CyQuant assay is performed. Fluorescent signal is used to determine 
relative cell proliferation. Mean values of each condition is calculated for each image 
and compared using ordinary One-way ANOVA, N = 3 cells for each condition. **p 
< 0.01. 
4.3.7 MTT Metabolism Assay 
To look at cell metabolic activity the MTT assay was used to compare CCL-210s 
on full-length Fn, FnIII9*10, and FnIII9-4G-10. When cells are plated on each recombinant 
fragment in decreasing concentration we see a decrease in cell activity indicating that the 
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presentation of the integrin binding domain to the cell’s integrins provides signals that 
trigger metabolic response within the cell in a controllable fashion. When comparing the 
Fn fragment to one another we do not see a significant difference in metabolic activity 
level; however, at coating concentrations ≤ 2µM there seems to be a trend that indicated 
that FnIII9-4G-10 has increased embolic activity.  
 
Figure 37. MTT analysis of cell metabolism at 24 hours on Fn and Fn variants. CCL-
210 cells are cultured on FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) 
and MTT assay is performed. Absorbance signal is used to determine relative cell 
metabolism. Mean values of each condition is calculated for each image and compared 
using ordinary One-way ANOVA, N = 3 cells for each condition. **p < 0.01, 
**p<0.001. 
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The significant differences noted in this experiment are highlighted as ** p< 0.001 
Fn having a higher metabolic rate over FnIII9*10 when comparing direct molar ratios of 
the proteins. Fn’s higher metabolic rate over FnIII9-4G-10 is less significant at ** p< 0.05 
when comparing molar ratios (0.1µM). Controls were utilized to look at low or full serum 
effects such as: low serum conditions do not proved as much exogenous Fn for cells to 
assemble and therefore there is a lessened effect on cell proliferation, BSA control is used 
to block binding of any other proteins to the surface and provides a weak cell binding 
protein for minimal cell adherence, TGFβ is believed to trigger myofibroblast phenotype 
so this was used as a positive control.  
4.3.8 Nuclear Localization of MRTF  
In order to quantify MRTF nuclear localization, MRTF immunofluorescence was 
compartmentalized between the nuclear Hoescht signal and the ‘cellular’ phalloidin signal. 
We can observe that on full-length Fn there is the most nuclear localization of MRTF. This 
is to be expected due to the complex structure of Fn providing many additional signals to 
the cell which may cause MRTF to localize to the nucleus. Controls CD (Cytochalasin D) 
and LatB (Latrunculin B) both toxins which affect actin polymerization respond 
accordingly, CD pushes MRTF to the nucleus and LatB pulls MRTF out of the nucleus. 
These results have great significance ****p <0.0001 when compared to FnIII9-4G-10. 
When comparing the Fn fragments (FnIII9*10 and FnIII9-4G-10) there is a significant 
different in nuclear localization of *p <0.05 in favor of FnIII9*10 (Figure 38). This is not 
the originally hypothesized result. Initially it was hypothesized that FnIII9-4G-10 which is 
believed to disengage the α5β1 integrin would be more myofibroblastic because it would 
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drive actin assembly and free MRTF fir nuclear translocation through its G-actin binding 
RPEL domains.   
 
Figure 38. MRTF nuclear localization analysis. CCL-210 cells are cultured on 
FnIII9*10 and FnIII9-4G-10 fragments (and full-length Fn) and immunostained for 
Hoescht nuclear stain, Actin, and MRTF-A. Single cells or multicellular aggregates 
are segmented based on actin and nuclear signaling, and MRTF signal in each 
compartment is background corrected (using intensities from the no primary 
control). Ratios of background corrected MRTF signal from the whole cells and from 
the nuclear compartment are used to estimate the nuclear fraction of MRTF. Single 
cell analysis is visible on the left with controls Cytochalasin D and Latrunculin B. 
Multicellular aggregates are depicted on the right to represent biological repeats. 
Mean MRTF nuclear localization values were calculated for each image and 
compared using ordinary one-way ANOVA with Tukey’s post-test, N = 40 cells for 
each condition. *p < 0.05 and ****p<0.0001. 
4.4 Discussion 
4.4.1 Differential Integrin Engagement through Recombinant Fibronectin IBD Effects on 
Downstream Signaling and Mechano-transduction 
Recombinant Fn IBD variants were engineered to mimic the biochemistry of normal 
and fibrotic Fn. We are interested in using these variants to interpret their promotion of 
various myofibroblast phenotypes like differential integrin engagement, differential focal 
adhesion composition, cellular morphology, proliferation, metabolism, and mechanical 
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signaling (MRTF). Differences in integrin engagement (mimicking the “integrin-switch” 
behavior described in Cao et al.) in normal lung fibroblasts was observed with FnIII9*10 
and FnIII9-4G-10 though not to the same degree as human dermal fibroblasts29. 
Immunofluorescent staining of CCL-210’s (normal human lung fibroblasts) integrin α5 
and αv should have characterized this integrin-switch behavior as well; however, the 
differences are not distinguishable. The slight reduction in α5 staining of cells on FnIII9-
4G-10 is not distinct enough to make conclusions that the integrin switch behavior is 
occurring. Although the trends mimic those seen with human dermal fibroblasts and HFFs 
it is unclear if these cells disengage α5 integrins when the RGD and “synergy” site are 
interrupted.  Myofibroblast differentiation has been shown to be controlled by multiple αv 
integrins such as αvβ5 and αvβ3 which may muddle the signal observed when comparing 
the ratio since only the influence of αv was observed and not the β3 heterodimer170,171.  This 
could influence the effect of the ratio when attempting to compare the ratio of α5 to αv. To 
clarify the effects that play into integrin engagement future studies could observe α5β1 vs 
αvβ3 with antibodies used to target the heterodimer pair.  
Paxillin was stained to observe length, concentration, and location of focal adhesions. 
It is observed that focal adhesions formed at early time points (1 and 3 hours) are visibly 
different on various Fn fragments. On full-length Fn there is indication of migratory cells 
as we can observe the leading and tailing edge of the cell indicated by the association and 
dissociation of focal adhesions respectively visible with paxillin immunofluorescent 
staining. At these early time points the cells on FnIII9-4G-10 seem to be concentrated, 
distinct, distal, and well-developed where as we do not see this effect on cells plated on 
FnIII9*10 until later time points (7 and 25 hours).  
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Also of interest was the resulting downstream signals that were associated with these 
focal adhesions. In the magnetic bead pull down assay a comparison of the engineered Fn 
fragments was utilized to observe differences in the mechano-transduction pathway. Our 
previous studies using the recombinant Fn IBD fragments have shown that FnIII9-4G-10 
has an increased affinity for αvβ3 integrin and FnIII9*10 more specific binds to α5β1 
integrin. Typically, mechano-transduction through integrin engagement triggers p-FAK 
prior to pSrc; however, our results from cells engagement with FnIII9*10 contrast this 
philosophy. 
In mechano-transduction, FAK Y397 will auto-phosphorylate after the activation of 
integrin and subsequently will provide a binding site for the SH2 domain of Src, leading to 
Src activation. Our results showed FnIII9-4G-10 involved mechano-transduction increases 
the phosphorylation of FAK significantly after mechanical stimulation and consistent with 
results on full-length Fn. Conversely, cells engaged with FnIII9*10 do not appear to have 
consistent demonstrable influence on FAK or Src phosphorylation levels. . To further tease 
out conclusions we can make about the cell interaction with FnIII9*10 there are few 
options to be explored. It is hypothesized that pSrc is upstream of pFAK, pSrc is signaled 
earlier than pFAK, or they are using different pathways then cells engaged on FnIII9-4G-
10172. Experimentation using Src or FAK inhibitors could be utilized to answer these 
questions.  
Previous studies showed the Src signaling pathway is directly downstream of receptor 
tyrosine kinase (RTK). To trigger the Src pathway (without phosphorylation of FAK) could 
occur due to growth receptors and cadherin engagement. It would be useful to explore the 
relationship that FnIII9*10 engineered fragment may have in engaging with other receptors 
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such as receptor tyrosine kinase or growth factor receptors. Ideally, further 
immunoprecipitation studies could be completed to determine whether FnIII9*10 can bind 
growth factor receptors and activate them through force to determine if this is what is at 
play with the downstream signaling effects. Additionally, Roca-Cusachs et al. explores the 
unique roles of α5β1 and αvβ3 integrins which could be implicated within these magnetic 
bead assays173. This work explores the relationship of α5β1 as an integrin responsible for 
adhesion strength and αvβ3 as an integrin related to mechano-transduction. These roles fit 
well with the results of the magnetic bead assay. CCL-210s exposed to FnIII9*10 
potentially favorably engage the synergy dependent α5β1 integrin indicated in their 
increased adhesion (crystal violet adhesion assay). Since this integrin is likely the primary 
influencer for cells on FnIII9*10 we do not see consistent mechanosensitive responses 
based on length of time of applied force. However, CCL-210s exposed to FnIII9-4G-10 
which likely disengage their α5β1 integrin engagement and preferentially favor αvβ3 (the 
believed mechanosensitive integrin) appears consistent with the influence of applied force 
on downstream mechano-related signaling proteins (significant increase of FAK 
phosphorylation).  
There is evidence linking focal adhesion formation with FAK phosphorylation and the 
assembly of the cytoskeleton. We explored this directly using MRTF nuclear localization 
(a known indicator of myofibroblast differentiation). Interestingly, we do not see a 
correlation between FAK phosphorylation and MRTF nuclear transport across the different 
Fn fragments. These results could indicated some differential early cellular adhesion 
kinetics that are implicated elsewhere in this work. It appears that there may be some initial 
kinetics that occur early on in the cell that are triggered based on integrin engagement and 
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some of these transduced signals may be influenced further down the cells lifetime. 
Previous work indicated MRTF engagement associated with adaptor protein or integrins, 
we can interpret that based on results from magnetic bead pull down and the differences 
apparent in downstream signaling there could be other factors affecting nuclear 
localization. The Fn molecule has many complex cues that provide cells many more 
opportunities to bind as well as triggering signals that continue to dictate cell phenotype 
besides sole engagement of varying integrins. The results from paxillin immunostaining 
can be used to compare how FnIII9-4G-10 and FnIII9*10 can affect lung fibroblast focal 
adhesion complex formation. The cell signaling events that occur within these focal 
adhesions such as paxillin expression and comparison on various substrates is compared 
with the results found through the magnetic bead pull down assay which indicates which 
signaling events are triggered by force application on the various ligands. FnIII9*10 
appears to engage a preference for α5β1 integrins but the focal adhesions visible with 
paxillin staining and the complexes associated with adhesions and force are less clear and 
more inconsistent. FnIII9*10 does appear to trigger MRTF nuclear localization, which 
appears to be contradictory to the original hypothesis that this conformation of Fn’s IBD 
would not drive myofibroblast differentiation. It is unclear if FnIII9-4G-10 preferentially 
engages αvβ3 integrin because the ratio of α5 to αv is not what has previously been seen 
in epithelial cells and HFFs which may be due to increased presence of other αv subunit-
containing integrins presented on CCL-210s. FnIII9-4G-10 has clear focal adhesion 
formation and has a consistent effect on FAK phosphorylation; however, there is 
significantly less MRTF nuclear localization indicating a less myofibroblastic phenotype. 
Some of these effects are counter hypothesis because we expected that FnIII9-4G-10 is 
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mimicking the extended conformation (disengagement of synergy effect of RGD and 
PHSRN) and we would anticipate that adhesion events associated with this spatially 
disjointed conformation would direct cells down a myofibroblast differentiation pathway. 
Factors at play may be other cell receptors that may bind to the variant fragments or the 
disengagement of α5β1 integrins has more impact on cell adhesion therefore less cellular 
persistence overall.  
4.4.2 Myofibroblast Phenotype Characterization Due to Conformational Bias of 
Recombinant Fibronectin IBD 
Myofibroblast phenotypes like proliferation, metabolism, cell contractility, and 
adhesion which are promoted by α5:αv engagement due to the hypothesized 
conformational bias of recombinant fibronectin integrin binding domain are explored here. 
Indications of slight differences in integrin engagement and observation of differences in 
adhesion proteins (FAK and Src) may influence further effects to phenotype. Our original 
hypothesis was that through biochemically mediated spatial decoupling of Fn’s IBD (RGD 
and PHSRN) there would be a shift towards myofibroblast differentiation. Evaluation of 
myofibroblastic characteristics such as cell contractility is analyzed in this work. It has 
been implicated that cells that appear larger and more polar are more contractile. Here I 
draw conclusions that a shift between a kinetic and steady-state effect of the recombinant 
Fn fragments is indicated.  
Cell surface area is measured for indication of cell contractility (increased 
spreading due to cytoskeletal formation and the cell forces linked to this). Appearance of 
polarity (less circular as the cell forces are increased) is used to draw a hypothesis about 
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the cellular responses of CCL-210s on the various fragments. Typically size and shape are 
correlated and it is expected that myofibroblast-like cells would be more polar. We have 
also shown in previous work with Fiore et al. that cell area and cell stiffness are directly 
correlated169. Size-wise at shorter time points (up until ~4 hours) cells on full-length Fn, 
FnIII9*10, and FnIII9-4G-10 are similar in size; however, cells on FnIII9*10 are more 
polar and, although this was not anticipated, it could be an indication that the cells have an 
initial response to the integrins they engage with but the effects that occur may influence 
longer term cell response differently. These results indicate that initially cells on FnIII9*10 
appear more contractile; however, as time passes and the cells begin to assemble their own 
matrix there appears to be a shift in the trend that may effect of some of the initial signals 
associated with early integrin engagement leading to downstream signaling and longer-
term phenotype. Another explanation for the shift is that CCL-210 cells are slower to 
engage FnIII9-4G-10 because FnIII9*10 allows engagement of both α5β1 and αvβ3 
whereas FnIII9-4G-10 is on expected to engage αvβ3 integrins. 
Cell adhesion can also be a useful indicator of cell phenotype. A cell’s adhesion based 
on the variable recombinant fibronectin fragments or full-length Fn is compared to better 
understand the structure and stability that the Fn variants provide and the influence this has 
on various cell activities. Our adhesion results indicated that FnIII9*10 induces greater cell 
adhesion than CCL-210s on FnIII9-4G-10. This could be a result of the integrin 
engagement on FnIII9*10 being increased since it also allows for engagement of α5β1 in 
addition to the αvβ3 integrin that is engaged on FnIII9-4G-10 as well. Again the adhesion 
effect observed here may be related to the association of α5β1 integrin with an adhesion 
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strength role. A more adhesive phenotype may indicate cell behavior linked to resistant to 
apoptosis. 
To observe some of the long term responses (up to 24 hours) other lung myofibroblast 
phenotypic characteristics were analyzed such as proliferation and metabolism. 
Proliferation is integral for the wound healing process and is increased in fibrotic tissues. 
It is also important to recognize that analysis of DNA synthesis within a cell may provide 
alternative results to those found using a metabolic assay. This is an interesting result 
because it may indicate that there are differences in integrin engagement and the effects of 
cell proliferation or metabolism individually and not as a combined effect. It may be that 
proliferation is more closely controlled by integrin engagement and overall metabolism is 
influenced more by underlying stiffness. It is also important to remember that metabolism 
can be regulated by many influencing factor not just those responsible for cell proliferation 
which may result in the differences between these responses. 
The MTT assay was used to make assumptions about the rate of metabolism in 
response to different ECM peptides mimicking spatial decoupling of Fn’s integrin binding 
domain. It is shown that recombinant Fn fragments that mimic the “strained” Fn 
conformation, FnIII9-4G-10, show an increase in cell metabolism in comparison to the 
“relaxed” conformation, FnIII9*10 at 24 hours. We see a shift in metabolism as 
concentration of Fn or recombinant Fn fragments decreases in concentration. Another 
observation is the trends that seem reasonable for the control samples (positive control is 
Fn with TGF-β, negative control with BSA). Proliferation observed with the CyQuant 
DNA synthesis Assay showed a differing influence affecting cell proliferation. In this assay 
FnIII9*10 was shown to have more influence on cell proliferation.  
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Although this CyQuant assay indicates as converse trend to what appears in the 
metabolism MTT assay this could be due what dictates metabolism and proliferation. It is 
known that myofibroblasts have higher rates of proliferation so this contradicts the original 
hypothesis that FnIII9-4G-10 fragments loss of α5β1 engagement would increase rates of 
proliferation. The higher metabolic activity on Fn is likely influenced by the many other 
binding sites available in the presence of full-length Fn. This difference in metabolic 
activity between FnIII9*10 and FnIII9-4G-10 is noteworthy because it may be one of the 
downstream phenotypes affected by earlier cell signaling events associated with the 
differential integrin engagement. This could indicate that cells on FnIII9-4G-10 are more 
“synthetic” and therefore potentially more myofibroblastic. 
The original hypothesis was that FnIII9-4G-10 would be myofibroblast inducer and 
that the FnIII9*10 would inhibit the myo-like differentiation; however this is not what is 
seen. Myofibroblasts would be more proliferative, contractile, synthetic, increased 
metabolism. Further studies to determine which integrins control the different phenotypes 
could be explored. One integrin may not control all different phenotypes since we looked 
at controlling biochemistry but only at a uniform stiffness. It is likely that mechanical and 
biochemical cues can interact and further work should be done on soft vs stiff substrates to 
determine what mimics the disease state vs native tissue. Comparing the combinatorial 
contributions of rigidity and the biochemical peptide presentation may provide an 
experimental system that more closely mimics nature.  As the Fn molecule experiences 
force and the typical integrin binding RGD and “synergy” sites are displaced a 
conformational bias can influence cell phenotype. Looking at many facets of cell behavior 
we can begin to understand and profile the ways that cells respond to their ECM as they 
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are stimulated with biochemical and mechanical cues. The differences observed may 
indicate that there is a kinetic influence and that over time the cell’s own matrix assembly 
may dissolve these differences; however, the long term effects on cell phenotype seem to 
be present. There is indication that the field needs further exploration of the influence of 
the specific integrins (including both α and β subunit) engaged and their effects on cell 
behavior for the CCL-210 cells. The conformational bias of recombinant fibronectin IBD 
may not have the impact originally hypothesized, and it may be need to be compared with 
underlying stiffness to further appreciate the biochemical influence.   
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CHAPTER 5. DISCUSSION AND FUTURE DIRECTIONS 
This thesis work began by asking if conformation changes to the IBD of Fn lead to 
differential integrin engagement and whether this shift in integrin engagement changes the 
phenotype profile that normal human lung cells will present. The original hypothesis 
included presumptions that when fibroblasts were disengaged with α5β1 integrins through 
the spatial separation of the RGD and synergy site that cells would become more 
myofibroblastic in phenotype, but the results we see are much more complex. When 
comparing the cellular behaviors associated with exposure to recombinant engineered 
peptides that mimic the RGD and PHSRN sites in stabilized (FnIII9*10) and spatially 
divided (FnIII9-4G-10) conformations to full-length Fn we can determine that other 
components of the Fn molecule must play a role in myofibroblast transition. The initial 
hypothesis was derived through our understanding of previous work indicated in Brown et 
al. that these recombinant fragments are able to guide epithelial transition30 and through 
work in Cao et al. where these fragments are used to visualize the “integrin-switch” with 
human foreskin fibroblasts (HFFs)29. However, the results presented through this thesis 
work indicate the complex nature of the effect that these recombinant proteins have on lung 
fibroblast phenotypes and our limited understanding of normal human lung fibroblasts. 
This work will inform further research to understand the role of integrins in cell phenotype 
for fibroblasts and the integrin profiles for lung fibroblasts as well as further examination 
of what drives fibroblast towards a myofibroblast phenotype as well as guide our definition 
of the myofibroblast phenotype.  
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Through the redesigning efforts of engineered recombinant FnIII9-10 fragments, 
we are able to explore the relationship of these specific Fn domains with the biochemical 
response to normal human lung cells and aid in the ability to examine the direct effect that 
the differential integrin engagement has on various cell phenotypes of interest in fibrotic 
tissues. Accompanying the redesign of these proteins came a streamlined high throughput 
process for protein expression and purification for ease of isolation of the desired peptides. 
These recombinant fragments utilize the integrin binding domain of Fn to explore the 
relationship with shifts in integrin binding profiles of cells on surfaces that have altered 
spatiotemporal effects. We have been able to further characterize the differences we see in 
integrin engagement when these different conformations of FnIII9-10 are presented and 
then further characterize some of the signaling events associated with these engagement 
events. Characterizing the shift of normal human lung fibroblasts as they become 
myofibroblasts based on mechanical stimuli in combination with biochemical molecule 
stimulation is key to understanding the events which ultimately trigger the uncontrolled 
constitutive activity of fibroblasts and how this ultimately leads to fibrosis.  
With the field’s continuing knowledge of the biological importance of integrin 
engagement in controlling cellular fate, we took a similar approach to specifically assess 
the contribution of Fn’s IBD on lung fibroblast phenotype. We found that there appears to 
be an initial integrin engagement which may slightly trigger α5>αv preference on 
FnIII9*10 engineered Fn fragment over what is seen on FnIII9-4G-10. It appears as if the 
engagement of αv integrin is similar for both cell lines but much more so on HFFs than 
what we see on CCL-210s. These lung fibroblasts seem to have this preference in integrin 
α5 on the FnIII9*10 however the difference is dampened from what has been shown in 
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other data we have represented in Cao et al. and there are many things that can explain this 
phenomena29. It could be conceived that these normal human lung fibroblasts have a 
different integrin profile or that other integrins such as αvβ5 and α3β1 may be engaged 
which may influence our staining ratios. Future studies looking at the integrins should 
consider doing FACS analysis to determine the integrin dimer pairs that are present on 
CCL-210s.  
When looking at general focal adhesion staining using an anti-paxillin antibody it 
is observed that on FnIII9-4G-10 there appears to be more clustered focal adhesions, 
greater length, more distinct and distal formations. This trend is apparent at shorter time 
points but the effect lessens as time passes and cells on FnIII9*10 have time to create and 
assemble adhesions. Another effect influencing longer time point cell adhesion is that 
fibroblasts will begin to lay down and assemble their own matrix proteins further muddling 
the signals seen based on the initial integrin engagement. The magnetic bead pull down 
assay that shows activation of different intracellular pathways appears to differ and 
maintain with up to 30 minutes of applied force. Cells plated in a dish are given time to 
associate with magnetic beads coated with the various ligands and when a magnet is 
applied, force is transduced and the effect on mechano-transduction influence on cells can 
then be interpreted. Initial studies on adhesion reinforcement revealed that cells are able to 
sense and respond to the restraining force (through matrix stiffening) applied to Fn-coated 
beads through strengthening and localization of cytoskeletal linkages165. The structural 
importance of adhesion strengthening and mechano-transduction is demonstrated based on 
force related FA proteins and its recruitment or activation at the site of exogenous force 
application174.  Although the FnIII9*10 beads associated adherent proteins FAK and Src 
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and their phosphorylation are unclear and inconsistent we are able to determine that under 
the influence of FnIII9-4G-10 beads and force increased phosphorylation of FAK is 
observed. This effect could mean that there are other factors at play. Previous studies 
showed that the Src signaling pathway is directly downstream of the receptor tyrosine 
kinase (RTK) including some growth factors receptors and integrin-tensin relationship 
after force activation172. Most of the current literature shows that Fn binds to growth factors 
but does not directly bind to growth factor receptors. Since our system used serum-free 
media there should be no growth factor present. Further immuno-precipitation 
experimentation need to be completed to determine if growth factor receptors are found 
directly bound and if they are activated with the addition of force. It is hypothesized that 
maybe cadherin or cell-cell junctions are playing a role affecting the different focal 
adhesion proteins which are controlling different downstream effects of mechano-
transduction. This work can also be compared to work looking at the role of α5β1 as an 
adhesion strength based integrin and αvβ3 as the integrin playing a key role in mechano-
transduction. 
In this work, lung fibroblasts are examined for their MRTF nuclear localization as 
this is a marker of myofibroblast transition and the results are unexpected. Although cells 
are only tracked at 90 minutes and 4 hours the trend that cells on FnIII9*10 have more 
nuclear localization of MRTF than when cells are on FnIII9-4G-10 is obvious and 
significant. Observation of cell shape and size to compare cell contractility is explored. 
Results indicate that at shorter time points cells on FnIII9*10 are larger and more circular 
but at longer time points (after ~2-3 hours) cells are larger and more circular on FnIII9-4G-
10. This could imply that cells at earlier time points which have not yet had time to fully 
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recognize and respond to their surface coatings may not be as pronounced and at longer 
time points that influence of the conformational differences of Fn are recognized and 
differences in size and shape are realized. When looking at proliferation we see that cells 
on FnIII9*10 are more proliferative then on FnIII9-4G-10. Metabolic rate is observed 
through an MTT assay and it is seen that FnIII9-4G-10 induces greater metabolic 
engagement. Since both proliferation and metabolic rate are examined at longer time points 
(~24 hours) it is useful to consider that it is possible that different integrin engagement has 
influence on proliferation or metabolism. Since metabolism is measuring cell activity the 
converse effect between proliferation is not shocking; however further exploration into 
what metabolic activities if not the activities that influence proliferation are being 
regulated. The hypothesis that cells have longer term downstream effects based on initial 
integrin engagement could be what is seen through this work.  
Through our advanced understanding of these relationships between matrix and 
fibroblasts we could propose that the effects between them could be as a result of much 
more than simply integrin engagement. It could be concluded that integrin engagement 
alone is not the determining factor that drives fibroblast to myofibroblast transition. We 
know that there is significant influence based on matrix rigidity and further exploration of 
the combined effects of biochemical cues via integrins and underlying substrate stiffness 
should be examined to see if these combined effects could better mimic the matrix 
environment40,42,166. Exploring the engineered fragments as a potential for mimicking 
specific cell behavior can be useful for continuing to probe therapeutic targets.  
 Further investigation into our H5 antibody that we have shown can preferentially 
bind FnIII9-4G-10 over FnIII9*10 can be further examined as a target. This phage-based 
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antibody can be optimized via directed evolution to increase affinity and used as a 
diagnostic tool and a therapeutic. Using the engineered fragments to test H5 as a potential 
therapeutic option could lay preliminary work with in vitro experiments.   
 Others in the field have previously explored the influence of Fn’s integrin binding 
domain on directing epithelial cell behavior; however, these approaches have not looked 
at lung fibroblasts specifically. Additionally it is important to better understand the role 
that Fn’s IBD has on lung fibroblasts in order to determine if therapeutic options which 
target “strained” imitators of Fn IBD are a viable option both in vitro and in vivo. Other 
groups such as Huang et al. have explored mechanical stiffness as a director of cell 
behavior towards a myo-like phenotype and towards myo-like cell behavior166. Although 
these conclusions were useful we should continue to explore the complete relationship 
between both the mechanical stimuli and presentation of binding interactions.  Our 
approach remains unique in that we determined that Fn IBD alone does not appear to direct 
lung fibroblasts in this way without mechanical stiffness associated and that there appear 
to be differences in short-term and long-term effects.  
 In the future, this work could be expanded upon in many ways to further understand 
lung fibroblasts and their transition to myofibroblasts during wound healing as well as the 
feed-forward loop that leads to lung fibrosis. This work sought to target this transition and 
how integrin engagement plays a role in this transition as a strategy to expand the field. 
However, to further explore the desired outcome, of increased understanding of 
fibronectin’s role in fibrosis and improved therapeutic options, there are other strategies 
that would need to be utilized. It is important to further understand the other components 
of the complex Fn molecule that are affected under protein unfolding that help potentiate 
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the myofibroblast lineage. The H5 phage-based antibody fragment would need to be 
characterized as a therapeutic inhibitor and more in vitro data would need to be considered 
before moving forward in vivo. Furthermore, investigation of mechanical stiffness via 
verifying hydrogel rigidity, should be done to further connect the myofibroblast transition 
via cues through mechanical stimuli and biochemical cues. 
The characteristics of the normal human lung fibroblasts that are observed after 
they encounter recombinant Fn IBD could indicate what the fibrotic ECM may look like 
and how cells respond to it. Characteristics like differential integrin engagement and the 
downstream effects that result from these differences were initially explored. The 
preliminary effects of the cell’s engagement with the recombinant Fn fragments can 
affect some of the phenotypic characteristics like phenotype, cell contractility, as well as 
other mechano-transduction effects. Based on conclusions from chapter 3 and chapter 4 
we could further investigate the combined effects of underlying substrate stiffness in 
combination with some of the phenotypes we observed. Determination of the expression 
of α-SMA, a known myofibroblast associated protein, could be analyzed in combination 
with stiffness. We could look at migration of cells on the Fn fragments or use a scratch 
assay to further understand the effects of the ECM on wound healing. Observing 
migration factors like speed or distance via DIC to do live cell imaging  could be 
performed to examine the migratory patterns of cells on full-length Fn, FnIII9-4G-10, and 
FnIII9*10. It could be expected that those cells which are more myo-like will be more 
invasive therefore will have increased migratory patterns providing information on cell 
behavior based on integrin binding specificity dominating attachment to the surface and 
the effect of this engagement over time. The myofibroblast characteristic of resistance to 
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apoptosis could be studied to better understand how the cells interpretation of integrin 
binding will affect the ability of a cell to become resistant to apoptosis and therefore 
remain persistent. 
Detailed information regarding fibroblast to myofibroblast transition based on 
ECM signals has yet to be obtained. Additional experiments could be done to elucidate 
and characterize cell behaviors by observing myofibroblast markers such as α-SMA, 
MyoD, and Myf-5 and considering underlying stiffness (soft 2kPa and stiff 18kPa) as a 
component that can contribute to myofibroblast differentiation in combination to the 
biochemical cues that are presented. Alternative methods could be used to further 
characterize cell contractility such as contractility AFM to observe the relative elastic 
modulus of cells on variable surface presentations in combination with surface stiffness. 
Another useful tool for looking at overall cell contractility would use traction force 
microscopy to analyze the traction force applied by cells on their surface that are utilized 
in the Curtis lab and portrayed in the work of Dumbauld et al.122  An ongoing 
collaboration with Khalid Salaita is focused on observing individual adhesion events 
using a FRET-like probe which would signal when the cell is pulling on the ECM which 
mimics similar studies done in Salaita et al.175-177 Further understanding these specific 
force results in combination with clarifying some of the work completed with the 
magnetic bead pull-down assay which indicates adhesion proteins associated with force-
induced mechano-transduction will be useful to further understand the cell signaling 
pathways associated with initial integrin engagement and the downstream effects on cell 
behavior. Imitating work by Huang et al.to utilize real time PCR to observe shifts of 
integrins or other interesting focal adhesion associated proteins on soft vs stiff underlying 
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substrate to further characterize matrix stiffness-induced myofibroblast differentiation in 
combination with the biochemical cues associated with the microenvironment during 
these changes166.  
An effective treatment for idiopathic pulmonary fibrosis is still elusive and the 
previously discovered antibody fragment, scFv H5, from Cao et al. could be explored as a 
potential therapeutic (Cao et al. to be submitted)83 29. It has been demonstrated that H5 can 
be used as a probe for fibrotic tissue in vivo so it could be have an application in targeting 
the fibrotic region. Recent reports suggests that αv integrins on myofibroblasts are 
implicated in fibrogenesis in a broad range of fibrotic diseases, and that pharmacological 
blockade of αv integrins ameliorates liver and lung fibrosis. The in vivo data our lab has 
generated regarding H5 staining of bleomycin-treated lungs are particularly interesting in 
the context of idiopathic pulmonary fibrosis (IPF). The lungs of IPF patients are 
mechanically and biochemically heterogeneous, with areas of soft, normal lung tissue and 
stiffer regions of mature fibrosis. The H5 antibody developed may be used to delineate 
regions of high ECM strain, perhaps indicative of active ongoing fibrosis. Further 
characterizing these events and better understanding how scFv H5 targets FnIII9-4G-10 
could assist in treatments for IPF as well as lead to a deeper understanding of cellular fate 
in regards to environmental biochemical and mechanical stimuli. 
It would be useful to further explore if scFv H5 could be used to inhibit fibrotic 
mimicking cellular responses. Another useful tool would be to obtain a crystal structure 
of FnIII9-4G-10 in combination with scFv H5 to better understand the relationship of 
how this antibody fragment binds to the ECM mimic (FnIII9-4G-10) and how this 
complex may mimic the occurrence on a larger scale.  We also aim to drive the shift from 
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the engagement of integrin αvβ3 to α5β1 by using H5 to block αvβ3 engagement. 
Another goal will be to use the H5 antibody to bring human lung fibroblasts back to 
normal adhesion phenotypes.  
One application of the H5 scFv could be to probe pathologic ECMs, specifically 
tumor stroma and fibrotic ECMs which contain highly contractile myofibroblasts. Recent 
reports suggests that αv integrins on myofibroblasts are implicated in fibrogenesis in a 
broad range of fibrotic diseases, and that pharmacological blockade of αv integrins 
improves liver and lung fibrosis178.  
 The ability of the H5 antibody to extract structural information from the ECM 
was also demonstrated in a model of retinal angiogenesis, the process by which new 
blood vessels form by endothelial sprouting179. In mouse tissue sections, regions of high 
H5:Fn ratio were found at the extensions of endothelial tip cells, suggesting that Fn is 
unfolded in these regions. Fn is known to be a mediator of retinal angiogenesis, wherein 
astrocytes deposit fibronectin prior to differentiation of angioblasts to endothelial cells180. 
Our results build on this foundation by suggesting that forces from endothelial tip cells 
unfold Fn, presenting an v3 binding character within the provisional matrix that may 
influence the formation of new blood vessels, a result further supported by the work of 
Segura et al. using engineered Fn fragments of the integrin binding domain in reparative 
angiogenesis29,141. 
 Understanding how tissue rigidity changes as a consequence of fibrosis and the 
influence this has on cell behavior is an essential component of determining therapeutically 
targetable mechanisms underlying the physical and biochemical microenvironment’s 
involvement in progression of fibrotic disease. Long term goals of discovering novel 
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molecular pathways for therapeutic intervention in IPF is essential and adding to the 
knowledge of the mechanisms that are linked to the pathophysiology of IPF are ideal 
targets to enable further studies to discover and test novel therapeutics. Before these studies 
are performed, it would be advised that further characterization of integrins in lung 
fibroblasts be analyzed. In contrast to the study outlined in this dissertation, it may be 
beneficial to look at the complex Fn molecule as a whole or within a 3D matrix to better 
understand the microenvironment seen by a cell. Work done by Smith et al. seems to 
convey that the experiments done on full Fn fibers provide a new level of insight to cell-
integrin relationships and cell behavior. Even though the conclusions of this work are that 
looking solely at the IBD of Fn as a biochemical promoter of individual integrin 
engagement and subsequent cell differentiation is not plausible; if considerations of 
mechanical stimuli through substrate stiffness were additionally explored then this work 
could still have significant benefit on mimicking the microenvironment of lung fibrosis 
and would allow for a platform to better understand cell behavior and potential 
therapeutics.  
 It is valuable to acknowledge the challenge of the simplicity of these peptides as a 
way to antagonize preferential integrin engagement and directing phenotype of fibroblasts 
to myofibroblasts as a necessary difficulty for the future progress in the field of bio-
mimetics of the matrix environment. It is realized that it is essential to combine substrate 
stiffness to imitate the changing lung micro-environment during the wound healing 
processes.  
 The overarching summary of this work is that Fn IBD alone may trigger differences 
in integrin engagement but this phenomena alone does not seem to be responsible solely 
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for myofibroblast transition in human lung cells. Although understanding how to direct 
myofibroblast transition is valuable to understanding how this relationship become 
dysregulated it is also useful for us to continue to explore systems that can mimic the 
environment to be able to best understand the factors that influence differentiation and 
dysregulation. Being able to have a platform for testing therapeutic options for IPF by 
observing their effect on cell behavior based on the local matrix is key for moving the field 




APPENDIX.  ADDITIONAL INFORMATION 
A.1  Thrombin Cleavage Site 
 The thrombin digest site is used for cleavage of the fluorescent protein tdTomato 
and His10 tag proteins after the first round of purification. This design feature was used to 
allow for protein expression visualization and for removal the affinity tag. After bovine 
thrombin is used to proteolytically digest the Fn fragments can be isolated further through 
another run through affinity chromatography which will entrap the tdTomato+His10 and 
allow for washing out of the purified protein. Figure A1 outlines the specific design of the 
thrombin cleavage site. 
Figure A1. Thrombin digest site between FnIII9-10 and tdTomato+His10.  
A.2 AKTA start Elution Profile 
The AKTA Start program was run using Unicorn 1.0 software to track the wash and 
elution steps during chromatography with a GE Healthcare Life Sciences FPLC AKTA 
start. Figure A2 shows the elution profile during gel filtration using a size exclusion 
Leu  Val   Pro  Arg  Gly   Ser  Pro 
CTG GTT CCG CGT GGA TCC CCG 
Thrombin 
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chromatography column. Visualized on the elution profile is the separation of FnIII9-4G-
10 from the tdTomato+His10 portions of the engineered protein after thrombin cleavage. 
It can be determined which fractions collected will contain each portion of the protein for 
further analysis. This technique is utilized to further purify the protein and verify its purity 
based on size.  
 
Figure A2. SEC AKTA profile of sample run after thrombin digest.  
A3. Formazen staining of cells during MTT Assay 
Visualized via microscope are the CCL-210 cells stained during the MTT assay. 
MTT is a yellow tetrazole which is reduced to purple formazan in living cells. Cells seen 
after 2 hours on substrates show differences in adhesion and proliferation based on coating 
substrate (Figure A3). After 24 hours the cell density is higher indicating proliferation has 
occurred and CCL-210 cells continue to have differences based on substrate coating 
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conditions however the trend is less visible by eye and is computed using a plate reader to 
verify absorption levels of the dye (Figure A4).  
Figure A3. Formazen cell dye used in MTT assay visible under microscope after 2 
hours of cell growth. 
Figure A4. Formazen cell dye used in MTT assay visible under microscope after 24 
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